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ABSTRACT 
Proliferation by cell division is essential for all living organisms and needs to be tightly 
controlled. While much is known about metazoan development, cell cycle control in bacteria is 
less well understood. The bacterial cell cycle is divided into three stages, the period from birth 
until the initiation of chromosome replication (G1); chromosome replication (S); and the time 
between the completion of replication and the end of cell division (G2). The lengths of G1 and 
the G1-to-S phase transition largely determine bacterial proliferation rates as the S and G2 
periods remain essentially constant over a wide range of growth rates. Although recent work 
has improved our understanding of cell growth and cell cycle progression, a molecular frame 
of the regulatory network driving G1/S transition is still largely missing. Caulobacter crescentus 
strictly separates its cell cycle stages in an eukaryote-like manner, initiating chromosome 
replication only once per division cycle. Moreover, Caulobacter divides asymmetrically to 
generate a replication-competent stalked cell (ST) and a morphologically distinct replication-
inert swarmer cell (SW). The latter remains in G1 for a defined period of time before 
differentiating into a ST cell, a process that is coupled to the initiation of chromosome 
replication. These unique features make C. crescentus a prime model organism to study 
bacterial cell cycle control.  
Recent findings suggest that C. crescentus cell cycle progression is controlled by oscillating 
levels of the second messenger c-di-GMP. While c-di-GMP levels are low in SW cells, a sharp c-
di-GMP increase directs the SW-to-ST cell transition and mediates S-phase entry when levels of 
the second messenger peak in stalked cells. In particular, c-di-GMP switches the cell cycle 
kinase CckA from kinase to phosphatase mode, thereby inactivating the response regulator 
CtrA, which in its phosphorylated form acts as a replication initiation inhibitor. Here we add 
another layer of c-di-GMP mediated cell cycle control. We show that c-di-GMP orchestrates 
the G1/S specific gene expression program by activating the ShkA-TacA phosphorylation 
pathway. The phosphorylated form of TacA, TacA~P, acts as a transcription factor for several 
genes involved in the morphogenetic program and in preparing cells for S phase entry. A 
combination of genetic and biochemical experiments revealed that c-di-GMP controls the 
ShkA-TacA pathway by directly binding to the ShkA sensor histidine kinase to strongly 
stimulate its kinase activity. Upon c-di-GMP mediated autophosphorylation, ShkA transfers 
phosphate to its C-terminal receiver domain from where it is passed on via the 
phosphotransfer protein ShpA to the transcription factor TacA. We demonstrate that c-di-GMP 
binds to a pseudo-receiver domain, which is positioned between the kinase core and the 
receiver domain and inhibits ShkA kinase activity. Alleviated ShkA auto-inhibition leads to the 
activation of the ShkA-TacA pathway. We show that c-di-GMP-mediated activation of ShkA and 
the subsequent c-di-GMP mediated proteolysis of ShkA together define a window of ShkA 
activity during the cell cycle. The activity of this pathway is further sharpened to a narrow G1/S 
specific period by TacA degradation, which precedes the degradation of ShkA. Thus, C. 
crescentus orchestrates G1/S specific gene expression in high temporal resolution through a 
combination of c-di-GMP mediated activation and degradation of ShkA-TacA phosphorylation 
components. Because ShkA binds c-di-GMP with higher affinity than CckA, the ShkA-mediated 
G1/S transcriptional network precedes the CckA switch leading to chromosome replication 
initiation as c-di-GMP levels are building up during the cell cycle. Together, these results 
propose a model, where an upshift of c-di-GMP drives consecutive steps of the G1/S cell cycle 
progression in C. crescentus by sequentially activating hierarchized phosphorylation pathways. 
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1 INTRODUCTION 
Bacteria are omnipresent in our environment and can survive and grow almost everywhere, 
even in extreme environments1. To live in different niches, bacteria have evolved a high variety 
of specialized enzymes, that can even be used in biotechnological applications2. Some 
industries rely heavily on bacteria, which are important for the treatment of wastewater3 or 
can be used to produce antibiotics. Bacteria can also be utilized for the production of amino 
acid on a million-ton scale, for example to produce the flavor enhancer Glutamic acid4. 
Traditionally, bacteria are an important component in the production of foods like yoghurt, 
cheese, sourdough, sauerkraut, or kimchi.  
Colonizing almost every ecosystem, bacteria are heavily involved in forming the biosphere of 
our planet. In the holobiont, the ecological system formed between plants and their 
microbiome, plants and bacteria influence each other and are interdependent5. On the other 
hand, bacteria can have a negative effect on plant growth, for example by leading to losses in 
food harvest6. Likewise, bacteria reside in and on the bodies of animals and humans. Bacteria 
can live in symbiosis with the animal or human hosts, affecting the metabolism and immune 
system positively7. Conversely, pathobionts invading the host’s microbiota can lead to 
infections. 
Because bacteria influence humans and their environment in so many ways, deepening our 
understanding of bacterial growth and behavior is essential for our well-being. Among others, 
this knowledge will help us to find treatments for infections, improve crop harvest, optimize 
industrial processes, and possibly solve the energy needs of our industrialized societies.  
1.1 REGULATION OF CELL CYCLE PROGRESSION 
Proliferation by cell division is essential for all living organisms and needs to be tightly 
controlled to provide appropriate numbers of specialized cells and to avoid pathological side 
effects like cancer. In metazoan tissue, stem cells need to proliferate and specialize. 
Coordinating cell division and cell differentiation is thereby central8. In eukaryotic cells, a 
highly complex network of cyclin-dependent kinases and protein degradation drives the 
process of the unidirectional cell cycle transition. Different cyclins oscillate to time the 
different stages in eukaryotic cell division. This process begins with the synthesis of specific 
cyclins at the beginning of the next cell cycle phase. These cyclins then activate cyclin-
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dependent kinases (Cdks) by binding to them. The so formed cyclin-Cdks complexes regulate 
specific events to progress the cell cycle like chromatin remodeling or centrosome duplication. 
Degradation then removes the current cyclin and thereby deactivates the Cdks. This allows the 
next cyclin to take over9. 
Conceptually, the aquatic bacterium Caulobacter crescentus controls cell cycle progression 
similarly to eukaryotes. In C. crescentus, three regulatory mechanisms drive the unidirectional 
cell cycle progression: A complex network of two-component systems advances cell division, 
and proteolysis specifically removes proteins that are not needed anymore. The third 
regulatory mechanism consists of the oscillating bacterial second messenger c-di-GMP to 
orchestrate the timing of cell cycle progression10. The following chapters will introduce each of 
these mechanisms in detail.  
1.2 SYSTEMS TO TRANSFER INFORMATION ACROSS THE MEMBRANE 
1.2.1 One-component systems 
The most widely used mechanism for prokaryotes to sense their environment is by utilizing 
one-component signaling systems. These systems consist of proteins with two specialized 
domains: An external input domain that senses a specific environmental signal, and an internal 
output domain that leads to a cellular response (Figure 1.1). One-component systems can sit in 
the membrane and sense environmental stimuli. The corresponding output is often carried out 
by a HTH domain that can bind to a ligand or DNA. For example, ToxR is a transmembrane 
transcription factor regulating virulence in Vibrio cholerae. ToxR consists of a cytosolic DNA 
binding domain and a periplasmic domain that senses pH and bile salts11. In a similar way, 
CadC in Escherichia coli also senses pH and induces the transcription of stress response 
genes12. One-component systems are encoded in the genomes of almost all bacteria and 
archaea13. This is exemplified by the archaeon Sulfolobus acidocaldarius that regulates 
swimming with the one-component system ArnR14.  
Proteins with a similar architecture can also remain in the cytosol where they bind 
environmental cues that can penetrate the cell envelope or are imported. One example for a 
cytosolic one-component regulator is the tetrameric E. coli protein LacI. LacI binds to the 
promoter of the lac operon and inhibits transcription by forming a DNA loop15. In its DNA 
bound form, the LacI tetramer is stabilized by interactions between the regulatory domains. 
Binding of the LacI substrate allolactose or IPTG induces a hinge-like motion within the protein, 
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releasing this interaction. This leads to a conformational change in the DNA-binding domain, 
releasing LacI from the DNA16.  
One-component systems that reside in the membrane are limited in binding to DNA, while 
cytoplasmic one-component systems are restricted in sensing the outside. This limitation likely 
led to the evolution of two-component systems. In those systems, the input and the output 
domain are separated, and phosphorylation links the two proteins together. This separation 
allows the input domain to sit in the membrane, interacting with signals from the outside, 
while the output domain remains in the cytoplasm and can directly interact with DNA17. 
1.2.2 Two-component systems and phosphorelays 
Similar to one-component systems, two-component systems allow bacteria to respond to their 
environment. These systems fulfill many roles in cellular signaling circuits. The most basic set-
up consists of two proteins, the histidine kinase (HK) and the response regulator (RR). A sensor 
HK usually has an input domain and always two kinase domains, the catalytically active CA 
domain and the DHp domain with a conserved His residue that can be phosphorylated. The RR 
contains a highly conserved receiver domain with an Asp residue onto which the phosphate is 
transferred. This leads to a conformational change and an output (see below and Figure 1.1). 
Sensor histidine kinases can react to a wide variety of inputs, from light, temperature or gas to 
specific low molecular weight molecules like amino acids or nucleotides18. Upon sensing a 
signal, the HK autophosphorylates on the conserved His residue. Subsequently, the phosphate 
is then transferred to an Asp residue on the RR, which in turn activates an effector domain to 
carry out a task19. The basic two-component system can be adapted to a more complex 
phosphorelay (Figure 1.1). In this case the phosphorylation scheme is HisAspHisAsp over 
multiple proteins. Phosphorelays often involve hybrid kinases in which the histidine kinase and 
the first receiver domain are fused together, and phosphotransfer proteins that shuttle the 
signal to the response regulator20. These more complex systems can be used to branch a signal 
to multiple response regulators (one-to-many), for example in the E. coli chemotaxis pathway, 
or to integrate signals from multiple kinases on one response regulator (many-to-one)21. One 
example for a one-to-many pathway can be found in the central C. crescentus CckA-ChpT-CtrA 
pathway (see below). Here the phosphotransfer protein ChpT donates phosphoryl groups to 
the response regulators CtrA and CpdR, which act as transcription factor and as protease 
adaptor, respectively22.  
The function of a response regulator is ultimately determined by the biochemical activity of its 
output domain. These are diverse but consist mostly (63 %) of DNA binding domains23. These 
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domains include the OmpR-like winged-helix domain, the NarL four-helix helix-turn-helix 
domain, the NtrC-like helix-turn-helix domain and the LytR-like DNA binding domain with an 
unusual β-fold23. Alternatively, these domains can mediate protein-protein interactions24 or 
have an enzymatic output. For instance they can produce second messengers like bis-(3' 5')-
cyclic diguanylic acid (c-di-GMP) with a dedicated GGDEF domain25. Members of this protein 
family lacking an output domain are called single domain response regulators and can have 
multiple cellular functions. A prominent example is the E. coli chemotaxis protein CheY that 
mediates motility control via its interaction with the flagellar motor switch26 (Chapter 
Chemotaxis, Page 7) or DivK from C. crescentus, which in its phosphorylated form 
allosterically controls the activity of a histidine kinase, thereby interconnecting two 
phosphorylation pathways27 (see below).  
 
Figure 1.1: Schematic diagrams of a one-component system, a two-component system and a phosphorelay. (A) The 
most basic signaling system comprises of a single protein with an input domain and an output domain. (B) In 
general, two-component systems consist of a histidine kinase and a response regulator. The CA domain of the 
histidine kinase binds ATP with the highly conserved N, G1, F, and G2 box. The phosphate is transferred to the His 
residue of the DHp domain. The phosphate is then transferred to the Asp residue on the receiver domain of the 
response regulator. (C) The more complex phosphorelay extends on the two-component system in a highly modular 
fashion. With an additional receiver domain that is often fused to the histidine kinase, and a histidine 
phosphotransferase, the phosphorylation scheme is His-Asp-His-Asp over multiple proteins. Adapted from13,23. 
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Many sensor histidine kinases are bifunctional enzymes that can also act as 
phosphatases28,29. This allows the pathway to suppress nonspecific phosphorylation of its 
own response regulator. Additionally, by switching a sensor histidine kinase from its kinase 
to its phosphatase mode, the cellular function controlled by this pathway can be quickly and 
efficiently shut off30. 
Two-component systems are widely distributed in bacteria and are also found in all other 
domains of life. Their modular architecture makes histidine kinases and response regulators 
versatile signaling pathways, connecting a large variety of upstream signals with different 
downstream processes. However, even though input and output mechanisms are different, 
structure and function of the central domains involved in phosphorylation are well 
conserved23. Histidine kinases form homodimers and two domains define the cytoplasmic 
kinase core. The CA domain is catalytically active and binds ATP. Structurally it consists of a 
five-stranded β-sheet and three α-helices packed against it that form an α/β-sandwich31. This 
domain contains specific motifs, the N, G1, F, and G2 box, that form a highly conserved ATP 
binding cavity32. The phosphate is then transferred to the conserved His residue that resides in 
the DHp domain (Figure 1.1). This central kinase domain is responsible for dimerization, 
phosphotransfer and phosphatase activity. The DHp consists of two α-helices that form a four-
helix bundle with the other protomer33,34. A conformational change between the CA and the 
DHp domain, mediated by the input domain, regulates autophosphorylation by moving the CA 
domain towards the DHp domain35. The conformation of the loop at the base of the helical 
DHp dimerization domain determines whether the histidine kinase autophosphorylates in 
trans or in cis36.The catalytic mechanism of autophosphorylation is independent of cis- or 
trans-directionality, however it might be important for response regulator specificity37. The 
process of autophosphorylation and phosphotransfer is separated, as phosphotransfer 
requires the movement of the CA domain to free the access to the phosphorylated His residue 
for the receiver domain. However, these two reactions still occur simultaneously in 
neighboring protomers of a dimer. Each protomer then switches to take over the function of 
the other protomer with an conformational change, a process that might be triggered by the 
interacting receiver domain38. To control the activation of the pathway, two-component 
systems often display phosphatase activity. The phosphate travels back from the response 
regulator and is removed by the DHp domain of the histidine kinase. However, this is not just a 
reversal of kinase activity, as the His residue of the DHp domain is not phosphorylated in this 
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process39. Nonetheless, it was shown that conserved key residues in the DHp domain are 
necessary for phosphatase activity40.  
The abundance of two-component systems in many bacteria requires high specificity to avoid 
crosstalk between different signaling pathways. A small subset of coevolving residues in the 
interface of histidine kinases and response regulators is enough to determine specificity41. 
These amino acids can be artificially exchanged to change specificity of a histidine kinase to 
another response regulator42. Response regulators themselves contain highly conserved 
receiver domains, formed by a central five-stranded parallel β-sheet and five α-helices 
surrounding it43. Receiver domains are not passive, they catalyze their own phosphorylation 
and dephosphorylation reactions. For this reaction five essential residues are necessary: A 
divalent metal ion required for phosphorylation is bound by three Asp residues, while Lys and 
Thr/Ser residues are crucial for signal transduction44. Phosphorylation leads to a 
conformational change of the distal α4-β5-α5 surface, which in turn mediates interaction with 
the neighboring output domain protomer or with other proteins45.  
Examples of receiver domains without the key residues for phosphorylation can be found in 
multiple species46,47. Pseudo-receiver domains can act as sensory domains. CikA, a protein of 
Synechococcus elongates circadian system contains a pseudo receiver domain that binds a 
small organic quinone molecule. Upon binding of its ligand, the protein becomes quickly 
degraded. This allows the cell to measure light indirectly over the cells redox state48. Similarly, 
it was shown recently that a subclass of CheY-like single domain response regulators interact 
with the flagellar motor not in response to phosphorylation, but in response to binding c-di-
GMP (Nesper et al. 2017, in revision). 
In the more complex phosphorelays, as represented for example by the CckA-ChpT-CtrA 
pathway in C. crescentus, a histidine phosphotransferase shuttles the phosphate from the 
(hybrid) histidine kinase to the response regulator (Figure 1.1). Two different types of 
phosphotransferases can be found in bacteria: dimeric transferases like ChpT and monomeric 
transferases like ShpA from the C. Crescentus ShkA-TacA pathway. ChpT structurally represents 
a histidine kinase, the CA domain however is not functional. The site of phosphorylation 
resembles a dimeric four-helix bundle similar to a DHp domain49. The monomeric ShpA also 
forms a four-helix bundle, but different to ChpT it has no degenerate CA domains50.  
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1.2.2.1 Chemotaxis 
The best understood example of bacterial signal transduction is chemotaxis. Many free-
swimming bacteria and archaea move towards attractants, or away from repellents, by sensing 
molecule concentrations. E. coli perform a biased random walk by measuring changes of 
gradients while swimming in one direction. Worsening conditions or no gradient change leads 
to earlier tumbling and directional change. This means bacteria can sense current ligand 
concentrations and remember past ligand concentrations at the same time51. Transmembrane 
chemoreceptors, called methyl-accepting chemotaxis proteins (MCPs), mediate this behavior. 
MCPs form a complex together with the histidine autokinase CheA and its regulator CheW. 
Phosphorylation activity of CheA is dependent on ligand binding and receptor sensitivity, 
which in turn is regulated by methylation of specific modification sites. Methylation of these 
sites decreases receptor sensitivity to its ligand, likely by inducing conformational changes52.  
Without ligand, CheA is active and phosphorylates the response regulator CheY, which 
interacts with the flagellar motor to induce tumbling. After ligand binding of the MCP, the 
kinase is turned off, leading to dephosphorylation of CheY by the phosphatase CheZ and 
subsequently longer swimming phases. In this state, the methyltransferase CheR decreases 
sensitivity of the MCP to its ligand by methylating specific sites in the dimer. The subsequent 
loss of ligand binding means that a steady or decreasing ligand concentration activates CheA. 
As a consequence, CheA phosphorylates and thereby activates the methylesterase CheB. The 
removal of methyl-residues increases MCP sensitivity once again. In addition, CheA activity 
also induces tumbling, allowing the bacterium to change direction. This feedback loop leads to 
a memory of a few seconds53 (Figure 1.2).  
Although MCPs in E. coli  are the most studied and best understood, this unique prokaryotic 
chemotaxis system is highly conserved in bacteria genomes54. In C. crescentus, 
chemoreceptors are expressed only in the swarmer cells and localized to the flagellar pole 
where they are partially ordered in a complex array, similar to other bacteria55. E. Coli MCPs 
expressed in C. crescentus are localized to the same pole, further emphasizing the highly 
conserved nature of these receptors56. Initial binding of a ligand leads to a small 
conformational change within the receptor dimer. This conformational change is then 
transmitted through the entire array, greatly amplifying the initial signal57.  
Next to many repellents and attractants like sugars and other nutrients, bacterial chemotaxis 
can also react to AI-2, a general signal of quorum sensing58. 
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Figure 1.2: Chemotaxis pathway: Methyl-accepting chemotaxis proteins (MCPs) form a complex with the histidine 
autokinase CheA and its regulator CheW. CheA is only active when no ligand is bound to the MCP and its 
phosphorylation activity controls two separate modules: (1) Motor control and (2) sensory adaption. (1) Motor 
control is achieved by the phosphorylation of the response regulator CheY. CheY switches the flagellar motor from a 
CCW rotation to CW rotation, leading to tumbling. When no ligand is bound and CheA is inactive, the phosphatase 
CheZ inactivates CheY, leading to a longer swimming phase. (2) Sensory adaption allows the bacterium to respond 
to ligand gradients. Without a ligand bound, CheA phosphorylates the methylesterase CheB, thereby activating it. 
Removal of methyl-residues from the MCP increases its sensibility until it can bind a ligand. This deactivates CheA 
and allows CheR to methylate the MCP to decrease sensibility of the ligand. Together, these two modules allow the 
adaption to molecule gradients. If a ligand concentration remains steady or decreases, MCP sensibility will decrease 
and induce tumbling, while at the same time increasing MCP sensibility again. Adapted from57.  
1.2.2.2 Chemoreceptors with other functions 
Apart from the mediation of chemotaxis, chemoreceptors can also have other functions, many 
of them unknown. Chemoreceptors are structurally diverse and frequently found in bacteria59. 
In Pseudomonas aeruginosa, the Wsp signal transduction complex is homologous to 
chemoreceptor systems mediating chemotaxis. However, in this case activation of the 
chemoreceptor WspA leads to an increase of biofilm formation60. The homologue of CheY in 
this system, WspR, has an GGDEF-domain that produces c-di-GMP. WspA is very similar to 
other MCPs, but it is not localized to the cell pole due to few amino acid changes61. Another 
example in the same bacterium is the Chp system. Upon receiving its signal, it modulates cAMP 
levels and twitching motility62. 
  Introduction | 9 
1.3 PROTEOLYSIS 
For all domains of life, it is a necessity to remove proteins in a controlled fashion. Protein 
homeostasis must be upheld by the degradation of damaged proteins or protein fragments 
from mistranslation or cleavage. Just as important is protein degradation to control cellular 
processes like cell-cycle progression or differentiation, and degradation as a stress response. 
Responsible for the active removal of proteins are oligomeric AAA+ proteases63. Numerous 
AAA+ protease complexes exist in bacteria with the basic architecture of an AAA+ ring that 
denatures proteins, and a compartmental protease degrading the proteins64. In the 
paradigmatic AAA+ protease ClpXP complex, the chaperone ClpX targets specific proteins to 
deliver them to the protease ClpP. ClpXP can thereby even degrade aggregated proteins that 
form under stress conditions65. In C. crescentus, ClpXP is essential. This is due to the toxin SocB 
that accumulates and leads to cell death without degradation by ClpXP. If SocB is lacking, ClpX 
can be deleted, however affected cells show deficits in growth and morphology66.  
ClpX recognizes proteins by short and unstructured peptide sequences. One example is the 
SsrA-tag in E. coli that is recognized by both ClpXP and ClpAP. The SsrA tag is added to proteins 
when translation is stalling and allows the cell to quickly remove these potentially harmful 
protein fragments67. Another example is the phage protein MuA, which is also recognized by 
ClpXP68. In total, ClpXP binds to at least five different degradation motifs, three N-terminal and 
two C-terminal. The C-terminal motifs share either homology with the hydrophobic SsrA 
recognition motif (LAA-COOH) or the MuA recognition motif (RRKKAI-COOH)69. Two proteins 
that are targeted by ClpXP with an SsrA homology motif are the C. crescentus proteins CtrA 
(NAA-COOH) and TacA (EAG-COOH). This specificity can be negated with a double mutation of 
the C-terminus to the negatively charged amino acid aspartic acid, for example in TacA with 
EAG-COOH to EDD-COOH70. 
The SsrA tag requires another protein, SsrB, to be efficiently targeted to its protease. SsrB 
thereby acts as an adaptor of SsrA71. Adapter proteins expand and diversify the substrate 
recognition capabilities of proteases and allow specific cell responses to altering conditions72. 
In the Gram-positive bacterium Bacillus subtilis, CtsR is a repressor of clp gene expression and 
therefore proteolysis. CtsR is active at a basal level under normal conditions. When exposed to 
stress, the protein McsA was found to activate the adapter protein McsB. McsB targets CtsR to 
the protease ClpCP where it is degraded. Subsequently, this allows the upregulation of stress 
response genes73. Adaptor proteins can also modulate protease specificity directly. The 
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adaptor ClpS binds to the protease ClpAP and inhibits degradation of SsrA-tagged proteins. At 
the same time, ClpS enhances degradation of protein aggregates74. 
Protein degradation is often part of cell cycle regulation and then needs to be exactly timed 
and regulated. This additional level of control can also be achieved with adaptor proteins, 
allowing the degradation of a specific target at a specific time75. The adaptors themselves are 
also degraded by ClpXP, however they are shielded from degradation by binding their specific 
substrate76. 
1.4 SECOND MESSENGERS IN BACTERIA 
1.4.1 The role of c-di-GMP 
C-di-GMP was first described as a regulator of cellulose synthesis in Acetobacter xylinum77, and 
is now recognized as a major second messenger that coordinates major decisions in bacterial 
life style and in cell cycle progression78. In general, cells low on c-di-GMP are motile, while a c-
di-GMP increase switches the cell to a sessile lifestyle in multicellular biofilms (Figure 1.3). In 
addition, c-di-GMP is thought to be involved in regulating virulence. While motile low-c-di-
GMP bacteria are responsible for acute infections, high-c-di-GMP cells are involved in chronic 
infections79. 
The second messenger c-di-GMP itself consists of two guanine bases that are linked to a cycle 
by ribose and phosphate80. It was suggested that c-di-GMP binds to its target likely as a 
dimer81. However, under physiological conditions c-di-GMP is most likely available as a 
monomer82. Within the bacterial cell, c-di-GMP levels and the complex, corresponding 
responses are regulated by the antagonistic action of diguanylate cyclases that produce c-di-
GMP, and phosphodiesterases that degrade c-di-GMP77,83,84 (Figure 1.3). These proteins are 
widespread and abundant in bacterial genomes85. 
The asymmetric cell cycle of C. crescentus is strongly dependent on c-di-GMP with the 
swarmer cell having low levels and the predivisional and stalked cell having higher levels of c-
di-GMP86. A mutant strain lacking all diguanylate cyclases (cdG0) loses cell polarity and cell 
differentiation, expresses no stalks, pili, holdfast, or flagellum, resulting in a phenotype of 
elongated and apolar cells87. 
While c-di-GMP is abundant in the phylum Proteobacteria, c-di-GMP is absent in other phyla 
like Bacteroidetes or Fusobacteria88. However, these bacteria could potentially be controlled 
by other second messengers like c-di-AMP. Interestingly, in some bacteria of the phyla 
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Firmicutes and Actinobacteria, both signaling systems, c-di-AMP and c-di-GMP, might be 
present89.  
1.4.2 Diguanylate cyclases and phosphodiesterases 
Diguanylate cyclases contain a GGDEF domain which is necessary for c-di-GMP production90. 
GGDEF domains are highly conserved over bacterial kingdoms and the domain itself is 
sufficient for c-di-GMP production, however regulatory domains are necessary for high 
activity91. GGDEF domains act in a similar way as adenylate cyclases, however with a different 
nucleotide-binding mode. For c-di-GMP synthesis, two GGDEF domains are necessary, 
requiring dimerization of the diguanylate cyclases92. For c-di-GMP formation, it is likely that 
two GTP molecules have to be arranged in a antiparallel orientation by the GGDEF domains93. 
Different mechanisms have evolved to achieve this interaction between GGDEF domains that 
provide a regulatory basis for c-di-GMP synthesis94. Additional control of c-di-GMP production 
is provided by allosteric inhibition of some GGDEF domains by c-di-GMP itself95. 
As direct antagonists to diguanylate cyclases, phosphodiesterases hydrolyze c-di-GMP. One 
major class of phosphodiesterases contains an EAL domain. This domain hydrolyzes c-di-GMP 
into linear dimeric GMP (pGpG) in an Mg2+ or Mn2+ dependent manner. In contrast, Ca2+ can 
inhibit phosphodiesterase activity96. The activity of some phosphodiesterases is dependent on 
allosteric activation by GTP. In this case, inactive GGDEF domains can regulate EAL domains by 
binding the required GTP97. Activity of EAL domains can be regulated by conformational 
changes induced by an input domain that catalytically optimizes the active site. This is the case 
in the light-sensing protein BlrP1 in Klebsiella pneumoniae98. The product of 
phosphodiesterases with EAL domains pGpG needs to be further hydrolyzed. In P. aeruginosa, 
the oligoribonuclease Orn can degrade pGpG to two GMPs and thereby remove pGpG from the 
cell99. 
Another widely distributed type of phosphodiesterases utilizes HD-GYP domains to directly 
convert c-di-GMP to two GMPs100. However, a first hydrolysis step produces pGpG. HD-GYP 
domains can also accept pGpG as a primary substrate and further hydrolyze it to two 
GMPs101,102. 
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Figure 1.3: Diguanylate cyclases containing a GGDEF domain produce c-di-GMP from two GTP molecules. Removal 
of c-di-GMP is carried out by phosphodiesterase with either an EAL domain, producing linear dimeric GMP (pGpG), 
or an HD-GYP domain that hydrolyzes c-di-GMP to two GMP in a two-step process. High cellular c-di-GMP levels are 
generally associated with a decreased motility, biofilm formation and modulated virulence. 
1.4.3 C-di-GMP receptors 
A broad variety of c-di-GMP receptors can be found in bacteria. A strong and common c-di-
GMP receptor is resembled by PilZ domain proteins that can be found in various bacterial 
species84. PilZ domains can be dimeric or monomeric and express a wide-range of mechanistic 
principles and binding stochiometries. However, in general they lead to a allosteric 
rearrangement with a hinge-like movement, after c-di-GMP binds to the PilZ signature 
consensus RxxxR103.  
GGDEF domains can also bind c-di-GMP and act as receptors95. An example of a c-di-GMP 
receptor with a degenerated GGDEF motif, which is catalytically inactive, is the C. crescentus 
adaptor-protein PopA104. In a similar way, degenerate phosphodiesterases can act as a c-di-
GMP receptors with an inactive EAL domain. This is the case for FimX, a P. aeruginosa 
protein105.  
It is important to note, that many c-di-GMP receptors do not show a common motif or a 
conserved domain. An example without a general c-di-GMP-binding domain can be found in P. 
aeruginosa, where the transcriptional regulator FleQ is de-repressed upon binding to c-di-
GMP106. In C. crescentus, the histidine kinase CckA binds c-di-GMP on its CA domain. This leads 
to an interaction with the DHp domain that allows the kinase to switch from a kinase to a 
phosphatase state29. 
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Not only proteins can bind c-di-GMP. A special class of c-di-GMP binders is represented by RNA 
molecules. C-di-GMP binding bacterial riboswitches are highly specific and can undergo a 
global structural rearrangement upon ligand binding107. Riboswitches can have multiple 
functions and c-di-GMP binding can regulate transcriptional regulation or translation108. One 
example is the Vibrio cholerae class I riboswitch Vc1 that, in response to c-di-GMP, positively 
regulates downstream gene expression of a colonization factor 109.  
1.4.4 Alternative second messengers in bacteria 
Apart from c-di-GMP, many more linear and cyclic nucleotides are known to act as second 
messengers in bacteria. These signals include cAMP110, cGMP111, (p)ppGpp112, c-di-AMP113 and 
even hybrid cyclic AMP-GMP molecules114 that are involved in pathogenicity of bacteria115.  
The second messenger cAMP was first described as an alarmone in in E. coli, that responds to 
glucose levels116. In low-glucose conditions, cAMP is produced by an adenylate cyclase and 
regulates biofilm formation positively117. However, cAMP is recognized as an essential signal 
involved in bacterial virulence in several pathogens by now118.  
The linear nucleotide (p)ppGpp is another alarmone that is synthesized under stress conditions 
or during starvation. Thereby, (p)ppGpp can have a multitude of effects on bacteria including 
development and virulence119. In C. crescentus, the enzyme SpoT synthesizes (p)ppGpp under 
starving conditions. Increasing levels of the (p)ppGpp alarmone influence levels of the proteins 
DnaA and CtrA directly, inhibiting G1-to-S phase transition and keeping the cell in the 
swarming state120.  
Several Gram-positive bacteria where shown to use the second messenger c-di-AMP. There, c-
di-AMP can control essential processes like cell wall homeostasis or ensures DNA integrity89. In 
Bacillus subtilis and related pathogens, c-di-AMP is essential and controls potassium 
homeostasis121.  
As many of those molecules were only discovered recently and considering the abundance of 
GGDEF domains in bacterial genomes122, it is likely that even more roles of second messenger 
signaling in bacteria will emerge in the future. 
1.5 ALPHAPROTEOBACTERIA 
Alphaproteobacteria is an omnipresent class of gram-negative bacteria with diverse ecological 
niches, from free-living environmental species to host-associated pathogens123. For example, 
the intracellular pathogen Rickettsia prowazekii that is responsible for epidemic typhus in 
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humans124, is also thought to be a close ancestor to mitochondria125. Alphaproteobacteria can 
have positive or negative effects on plants. The plant family Leguminosae can form a specific 
symbiose with many different Rhizobiales, for example Rhizobium, to fix atmospheric 
nitrogen126. However, plants can be affected by the pathogen Agrobacterium tumefaciens that 
can ontogenically transform plant cells127. Some Alphabroteobacteria can grow under extreme 
conditions, like Polymorphobacter multimanifer that lives within stones in Antartica128. 
Even though there is a high diversity in Alphaproteobacteria, the cell cycles of bacteria in this 
class still rely on similar mechanisms with conserved central pathways129. The oligotrophic 
bacterium C. crescentus is a bacterial model organism with an obligate asymmetric cell division 
that gives rise to two distinct cell types, a motile replication-inert swarmer cell and a sessile 
replication-competent cell130,131. 
1.6 CAULOBACTER CRESCENTUS 
The ubiquitous Caulobacter genus was initially defined by the ability to form stalks132. Stalks 
are cell envelope extensions that are always polar in Caulobacter, however can also be 
subpolar or bipolar in another Alphaproteobacterium genus, Asticcacaulis133. The stalk of 
Hyphomonas neptunium, also belonging to the same genus, is directly involved in cell division. 
This bacterium uses a budding mechanism, in which the daughter cell grows at the end of the 
stalk. In this asymmetric process, the emerging cell does not have a stalk134. In C. crescentus, 
stalks are the hallmark of the replication-competent cell type. The cytoplasmic composition of 
the stalk lacks most proteins of the cell body, however it includes proteins for nutritional 
uptake135. In addition, the long and thin form of the stalk is ideal for the uptake of diffusing 
nutrients136. The end of the stalk consists of a strong adhesive holdfast, allowing the bacterium 
to attach to surfaces137,138.  
After cell division, genome replication is inhibited in the motile swarmer cell (G1 phase). 
During the irreversible transition into a sessile stalked cell (S phase), the cell starts the 
replication cycle. Swarming daughter cells are then shed off from the opposite pole of the 
stalk139 (Figure 1.4). If the new-born swarmer cell is in contact with a surface, a holdfast is 
immediately formed140. The characteristic curved (crescent) shape of C. crescentus helps the 
predivisional cell to contact the surface, enhancing colony formation141.  
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Figure 1.4: The C. crescentus cell cycle: Motile swarmer cells differentiate to sessile stalked cells by losing the 
flagellum and pili, replacing them with a holdfast and later the stalk. The stalked cell begins replication of the 
genome, initializing an asymmetric cell division. The stalked cell remains replication-competent, while the daughter 
cell differentiates into a replication-inert swarmer cell. The orange color indicates rising c-di-GMP levels during G1-
to-S phase transition, while the swarmer cell does not have c-di-GMP (blue). The peak of c-di-GMP levels is 
qualitatively shown as a grey curve.  
  
16 | Introduction 
1.7 CAULOBACTER CRESCENTUS CELL DIVISION 
To undergo the complex process of cell differentiation and division, C. crescentus uses an 
intricate set of mechanisms that is tightly controlled. Protein expression, levels of c-di-GMP 
and protein degradation together irreversibly allow the cell to transit through G1-to-S-phase. 
The following chapters describe the C. crescentus cell division in detail.  
1.7.1 The initiation of chromosome replication 
A central step of cell division is the controlled replication of the chromosome. In bacteria, a 
single origin of replication (oriC) acts as starting site for chromosome replication. This genetic 
region likely encodes species-specific instructions for the binding and regulation of proteins 
that form the initiation complex. Core of the initiation complex is the initiator protein DnaA. 
The dnaA gene is present in almost all bacteria with the exception of few obligate 
endosymbiotic species142.  
As an AAA+ type protein, DnaA binds ATP with high affinity and after reaching peak level, 
forms multimeric complexes on the oriC region. Mediated by this complex and other proteins, 
duplex DNA can unwind and the DNA helicase is allowed to initiate the construction of 
replication forks143. In fast growing bacteria like E. coli, another round of replication can be 
initiated before duplication has finished, dramatically speeding up cell division time. C. 
crescentus on the other hand is limited to one replication cycle at the time144.  
DnaA is controlled on many levels, including expression, ATP hydrolysis and ultimately protein 
degradation145. However, C. crescentus adds an additional layer of control. While DnaA 
oscillates in the stalked cell to constantly replicate the chromosome, DnaA is inhibited in the 
swarmer cell by the response regulator CtrA. There, CtrA in its phosphorylated state binds to 
the oriC and thereby silences the origin of replication, ensuring the asymmetric life cycle of C. 
crescentus. For replication to start, CtrA has to be dephosphorylated and subsequently 
removed from the cell146.  
1.7.2 The master cell fate regulators of Caulobacter crescentus control the CckA-ChpT-CtrA 
pathway and c-di-GMP levels during the G1-to-S phase transition 
Central in C. crescentus cell division is the activity and the localization of the kinases DivJ and 
PleC, which control the master cell fate regulator DivK in a complex phosphorylation 
network147. These factors together control the activity of the CckA-ChpT-CtrA pathway and 
modulate c-di-GMP levels within the cell, which in turn together influence protein 
degradation148.  
  Introduction | 17 
The central transcription factor CtrA is essential for C. crescentus cell division and 
development149. In addition to controlling almost hundred cell cycle-regulated genes 
directly150, including TacA151, CtrA also specifically represses DNA replication in the swarmer 
cell by binding to the chromosome replication origin of C. crescentus. Therefore, to enter S-
phase, CtrA first has to be dephosphorylated and then removed from the swarmer cell during 
G1-to-S phase transition152. 
CtrA itself is regulated and phosphorylated by the essential histidine kinase CckA and the 
histidine phosphotransferase ChpT. ChpT branches the CckA-ChpT-CtrA pathway to 
additionally control the proteolysis adapter protein CpdR negatively153,154. CpdR first needs to 
be dephosphorylated to act as a polar localization factor and as an adaptor for ClpXP to 
degrade CtrA with the adaptor proteins RcdA and PopA155,156. This happens when CckA 
switches from a kinase to a phosphatase during G1-to-S phase transition, dephosphorylating 
ChpT and subsequently CtrA and CpdR157. This kinase to phosphatase switch is promoted by 
DivK which needs to be phosphorylated during swarmer to stalked cell transition. 
In the swarmer cell, PleC sits at the flagellated pole and acts as a phosphatase on DivK, thereby 
keeping it inactive and cytoplasmic. Early in the G1-to-S phase transition, DivJ kinase levels 
begin to rise. DivJ phosphorylates DivK and DivK~P is then localized to the pole158. This induces 
a positive feedback loop in which DivK~P switches PleC from a phosphatase to a kinase, which 
phosphorylates more DivK. Enforcing this feedback loop, DivK~P also enhances DivJ kinase 
activity further. PleC and DivJ together phosphorylate the diguanylate cyclase PleD, which 
leads to an increase of cellular c-di-GMP levels 27. 
To control the CckA-ChpT-CtrA pathway, DivK~P localizes to the pole and inhibits the 
noncanonical kinase DivL, a protein that keeps the CckA-ChpT-CtrA pathway active in the 
swarmer cell. DivL then localizes CckA to the pole159. However, some CckA is still present in the 
cytoplasm. There, c-di-GMP acts as an additional switch on delocalized CckA molecules to 
tightly move the entire cellular pool into phosphatase mode10. All these processes together 
release the cell into S phase. 
During the G1-to-S phase transition, DivJ is localized to the flagellated pole by SpmX and PopZ 
where the flagellum is shed, and the stalk and holdfast are produced151,160. PleC is then 
localized to the opposite pole by the freshly expressed localization factor PodJL in the 
predivisional cell161,162. There it likely sequesters DivK~P, allowing DivL to become active again 
and establishes the two cell fates after division163 (Figure 1.7). 
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1.7.3 Timed protein degradation is essential for the Caulobacter crescentus cell cycle 
In C. crescentus, a cascade of adapters guide proteins to ClpXP during the cell cycle. These 
adapters bind to each other in a hierarchical manner, and allow controlled degradation at 
specific time-points during G1-to-S phase transition156. The first adaptor for ClpXP is the CckA-
ChpT controlled protein CpdR. After the CckA kinase to phosphatase switch, this protein 
targets the phosphodiesterase PdeA for ClpXP degradation, allowing for an increase of c-di-
GMP levels in the cell. This corresponds with the activation of the diguanylate cyclase PleD164. 
In addition to binding to PdeA, the ClpXP-CpdR complex can also bind the next adaptor RcdA. 
RcdA targets the stalk regulator TacA and other proteins for degradation70,156. RcdA substrates 
compete with the last adaptor PopA. This means PopA can also act as an antiadaptor, 
inhibiting RcdA mediated degradation. To be active and degrade CtrA, PopA needs to bind c-di-
GMP. CtrA degradation is therefore dependent on high c-di-GMP levels104,156, meaning that 
protein degradation is closely linked to c-di-GMP control. This is also the case for the polar 
flagellum regulator TipF. TipF localizes to the pole upon binding to c-di-GMP where it recruits 
other factors involved in flagellar synthesis. When c-di-GMP levels are decreasing in the 
swarmer compartment of the predivisional cell, TipF is released from the pole and degraded by 
ClpXP165.  
Cleaving of the polar factor PodJ is a ClpXP independent example for complex proteolysis in C. 
crescentus. Two forms of PodJ are involved in the cell cycle, PodJL and PodJS. PodJL localizes 
PleC to the swarmer pole. Then the periplasmic protease PerP truncates PodJ to PodJS with a 
new function in chemotaxis and holdfast formation. Finally yet another protease MmpA 
releases PodJS into the cytoplasm where it can be degraded162. 
1.7.4 The ShkA-TacA pathway is necessary for G1-to-S-phase transition and development 
To initiate gene transcription, a class of proteins called sigma factors are needed. Two broad 
classes of sigma factors exist, the sigma 70 factor (σ70) family and sigma 54 factor (σ54) 
family166.  
Sigma factors guide the RNA polymerase specifically to the promoter and melt the DNA duplex 
to allow transcription. In this process, first the polymerase subunits assemble the core RNA 
polymerase complex. σ70 binds and targets the protein complex to two conserved sequences, 
generally located -10 and -35 nucleotides upstream of the transcriptional start site, and melts 
the DNA in the -10 region167.   
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The alternative σ54 family is structurally and functionally distinct from the σ70 family. In 
contrast to σ70, σ54 binds to a region -24 and -12 from the transcriptional start site with a highly 
conserved consensus168. σ54 expression can be temporally controlled. This is the case in C. 
crescentus, where the σ54 gene rpoN is expressed during the swarmer to stalked cell 
transition169. However, there is an additional level of control. The most significant difference to 
σ70 is given by the requirement of a bacterial enhancer binding protein (bEBP) to activate σ54 
transcription170. bEBPs bind 80 to 150 bp upstream of the transcriptional starting site. In order 
to initiate melting of the DNA, bEBPs need to interact with the RNA polymerase complex and 
require energy from ATP171. According to the function of bEBPs, they consist usually of three 
domains: An AAA+ domain responsible for ATP hydrolysis, a domain containing a helix-turn-
helix (HTH) motif that binds to the DNA, and a regulatory domain to control the protein172. The 
regulatory domain can be very diverse or entirely missing. In many cases however, bEBPs are 
part of a two-component system and regulated by phosphorylation from a histidine kinase173. 
In C. crescentus, this is the case for the ShkA-TacA pathway. TacA is a transcription factor of 
the bEBP family174. In this pathway, TacA is controlled by the hybrid histidine kinase ShkA that 
is as part of a His-Asp phosphorelay involved in cell morphogenesis and development. 
Interestingly, this histidine kinase is predicted to lack any transmembrane or sensor domains 
and therefore belongs to a small subgroup of cytoplasmic regulators of which little is known. 
Adding to the unusual protein architecture are two receiver domains that are attached to the 
kinase domain. The first one is a pseudo-receiver domain, lacking key residues that would 
allow it to be phosphorylated. The second receiver domain can be phosphorylated and 
transfers its phosphate to the phosphotransferase ShpA. ShpA then phosphorylates TacA 
(Figure 1.5).  
The expression of tacA itself is dependent on CtrA and PleC151. The ShkA-TacA pathway is 
active early in the G1-to-S phase transition and quickly turned off by ClpXP degradation70,174. 
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Figure 1.5: The ShkA-TacA pathway resembles a traditional phosphorelay. However, ShkA does not have a 
transmembrane domain or an input domain. The pseudoreceiver domain of ShkA cannot be phosphorylated, due to 
residues missing that are essential for M2+ binding.  
 
Figure 1.6: Sequence analysis of the pseudo-receiver domain and the receiver domain of ShkA, reveals that the 
pseudo receiver domain cannot be phosphorylated (missing ion-binding site indicated in orange).  
One of the genes controlled by the ShkA-TacA phosphorelay is staR, which is a transcription 
factor involved in C. crescentus stalk biogenesis and responsible for controlling stalk length174. 
StaR is also involved in holdfast regulation by inhibiting the promoter of the hfiA gene. The 
HfiA protein inhibits HfsJ, a glycosyltransferase required for holdfast production175. Holdfast 
production is additionally controlled by c-di-GMP, in a StaR-independent fashion176. 
The other well-described target gene of TacA is spmX. SpmX is a lysozyme-like protein that 
localizes the DivJ kinase to the future stalked cell pole in the swarmer cell and activates DivJ to 
phosphorylate the cell fate determinant DivK151. The regulatory protein SpmY might influence 
spmX expression and ShkA-TacA pathway activity177. SpmX itself is localized to the pole by 
another factor, PopZ, by direct binding. At the pole SpmX forms oligomers of trimers160. PopZ 
tethers the centromere in the swarmer cell to the flagellated pole by interacting with the 
chromosome partitioning protein ParB178,179. During G1-to-S phase transition, PopZ switches 
function to act as a localization factor. Multiple proteins apart from SpmX need PopZ for 
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robust polar localization, including DivK, CpdR, RcdA, ClpX and CckA. PopZ remains its function 
at the stalked pole, however during replication, new PopZ localizes to the opposite pole 
regaining its centromere tethering function180 (Figure 1.7). 
 
Figure 1.7: Polar localization of key drivers of cell cycle progression in C. crescentus. The letter K indicates kinase 
mode, the letter P phosphatase mode. The peak of c-di-GMP levels is qualitatively shown as a grey curve. Low 
cellular c-di-GMP levels are indicated in blue, high cellular c-di-GMP levels in orange.  
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2 AIM OF THE THESIS 
The second messenger c-di-GMP controls C. crescentus development and coordinates this 
process with cell cycle progression.  Recently Lori et al. have shown, that c-di-GMP triggers S-
phase entry and replication initiation by controlling the histidine kinase CckA10. However, the 
role of c-di-GMP in gene expression during the G1-S transition has remained elusive.  
In a Capture Compound Mass Spectrometry (CCMS) screen, Jutta Nesper identified ShkA to be 
a putative c-di-GMP binder. Levels of c-di-GMP rise early in the cell cycle87 during the G1-S 
transition when also the ShkA-TacA pathway is highly active. 
The aim of my thesis was to investigate how c-di-GMP regulates the ShkA-TacA pathway to 
control cell cycle timing, gene expression and morphology during the G1-to-S phase transition.   
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3 PROJECT ABSTRACT 
The following chapters are based on the publication manuscript in preparation: 
A c-di-GMP controlled phosphorelay drives a 
bacterial cell cycle by inducing a G1/S specific 
transcriptional network 
Kaczmarczyk, A.*, Hempel, A.M.*, von Arx, C.*, Nesper, J., Jenal U. 
* Equal contribution / order to be discussed 
 
Bacteria can adapt their growth rates to the prevailing nutritional conditions. Proliferation 
rates are controlled by the cell cycle and are essentially determined by the step committing 
cells to initiate chromosome replication. The transcriptional network controlling this process is 
still largely unknown. Here we show that in the alpha-proteobacterium C. crescentus, a G1/S 
specific transcriptional network orchestrates entry into the replicative cycle. We demonstrate 
that fluctuating levels of the second messenger c-di-GMP control the ShkA-TacA 
phosphorylation cascade during the cell cycle, leading to the expression of a specific set of 
genes required to prepare cells for replication initiation and to coordinate this process with 
morphogenesis. C-di-GMP specifically binds to a pseudo-receiver domain of the ShkA kinase to 
alleviate its autoinhibitory function. This stimulates kinase activity, leads to the 
phosphorylation and activation of the TacA transcription factor and the activation of TacA-
dependent gene expression during the G1/S transition. We further demonstrate that c-di-GMP 
mediated activation of ShkA together with delayed c-di-GMP dependent degradation of TacA, 
limiting gene expression to a narrow window during the G1/S transition. This is reminiscent of 
G1/S control in eukaryotes where cyclins and cyclin-dependent kinases define the timing of the 
G1/S specific transcriptional network by a combination of controlled phosphorylation and 
protein degradation. 
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4 PROJECT INTRODUCTION 
Metazoan development and tissue homeostasis relies on self-renewal by quiescent stem cells 
that retain the capacity to re-enter the cell cycle. Conversely, misregulation of these cells 
results in uncontrolled proliferation and cancer181. A pivotal step of the cell cycle is the 
progression from G1 to S phase, which commits cells to chromosome replication and 
eventually to cytokinesis182,183. The transcriptional network regulating cell cycle progression is 
ultimately controlled by members of the conserved cell cycle machinery including cyclin-
dependent kinases and cyclins, their stage-specific regulatory subunits184,185. Cell cycle control 
in bacteria is less well understood. Bacteria need to coordinate cell growth and differentiation 
with their metabolic status and nutrient availability. Their cell cycle is divided into three stages, 
the period between birth and the initiation of chromosome replication (B period or G1); the 
period required for chromosome replication (C period or S); and the time between the 
completion of replication and the end of cell division (D period or G2)186. Since the C and D 
periods remain essentially constant over a wide range of growth rates187, the step committing 
cells to initiate chromosome replication largely determines bacterial proliferation rates. 
Moreover, chromosome replication initiates at a constant cell volume irrespective of the cell’s 
size at birth, indicating that this represents the initiating step of the bacterial cell cycle188,189. 
Although recent work has improved our understanding of how cell growth and cell cycle 
progression are coupled (reviewed in190,191), a molecular frame of the regulatory network 
driving G1/S transition is still largely missing.  
To accomplish rapid growth, bacteria like E. coli or B. subtilis can initiate new rounds of 
replication before completing previous rounds of genome replication187. In contrast, C. 
crescentus strictly separates its cell cycle stages in a eukaryote-like manner, initiating 
chromosome replication only once per division cycle192. This, and the fact that different stages 
of the cell cycle have distinct morphologies and can be separated from each other 
experimentally, makes C. crescentus particularly amenable to study bacterial cell cycle 
control193. Caulobacter divides asymmetrically to generate a sessile stalked cell (ST), which 
enters S-phase immediately and a motile swarmer cell (SW) that enters G1 phase, in which 
replication is blocked. After a defined period of motility, SW cells initiate a program to exit G1 
into S-phase. Concomitant with initiating genome replication cells change morphology and 
behavior by replacing the rotary motor with an extension of the cell body, the stalk, and an 
adhesive holdfast that anchors sessile ST cells to surfaces. Replication initiation requires the 
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accumulation of the essential and highly conserved initiator protein DnaA, which binds to the 
chromosomal origin of replication (Cori) to promote duplex unwinding and replisome 
assembly145,194–197. DnaA activity is antagonized by the replication initiation inhibitor CtrA, an 
essential response regulator, which in its phosphorylated form binds to several sites in the Cori 
and blocks replication initiation152. Levels of DnaA are low in G1 and raise above a threshold 
level during G1/S to initiate chromosome replication146. Conversely, CtrA is phosphorylated 
and active in G1 but is inactivated and rapidly degraded by the ClpXP protease prior to S phase 
entry104.  
CtrA activity is controlled by the central cell cycle kinase CckA, a bifunctional enzyme that can 
act both as kinase and as phosphatase to control CtrA phosphorylation via the 
phosphotransfer protein ChpT153,157,198. CckA is a kinase in G1, but switches to phosphatase 
mode upon entry into S phase, resulting in the inactivation of CtrA and clearance of the 
replication block. This central cell cycle switch is ultimately controlled by the cell fate 
determinants DivJ and PleC, two histidine kinase/phosphatase antagonists, which localize to 
opposite cell poles and during division asymmetrically partition into the daughters to 
determine their respective programs147. DivJ and PleC control the phosphorylation of a single 
domain response regulator, DivK, which in turn regulates CckA activity via its interaction with 
the pseudokinase DivL159,199. Because the G1 swarmer program is dominated by the PleC 
phosphatase, DivK~P levels remain low and CckA adopts default kinase activity. During G1/S, 
PleC is replaced by DivJ, leading to DivK phosphorylation which in turn stimulates the CckA 
phosphatase activity. According to this regulatory scheme, the appearance and activation of 
the stalked cell specific DivJ kinase represents a key step during G1/S transition. Activation of 
DivJ is directed by the SpmX scaffolding protein, which accumulates during G1/S and recruits 
the DivJ kinase to the incipient stalked pole151. Thus, SpmX is not only a critical element of the 
temporal control of DivJ during G1/S, but also ensures that DivJ partitions with the stalked 
daughter cell at the next cytokinetic event151. While this makes SpmX accumulation the earliest 
known event to trigger S phase entry, it is unclear how the G1/S-specific transcriptional 
network orchestrates spmX expression during the cell cycle. Transcription of the spmX gene is 
regulated by the response regulator TacA, which in its phosphorylated form also induces the 
expression of genes required for the SW-to-ST cell morphogenesis151,174. Although TacA was 
recently shown to be phosphorylated by the sensor histidine kinase ShkA and the the 
phosphotransferase protein ShpA, the signals that activate this phosphorelay have remained 
unknown. 
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Recent findings suggested that C. crescentus cell cycle progression is controlled by the 
guanosine-based second messengers ppGpp and c-di-GMP78,200. While ppGpp appears to delay 
G1/S transition by stabilizing CtrA120,201, c-di-GMP directs the SW-to-ST cell transition and 
promotes the entry of differentiating cells into the replicative cycle10,87,104. Levels of c-di-GMP 
are low in swarmer cells, increase during G1/S and peak in stalked cells concomitant with 
replication initiation27,86,87. One of the main drivers of c-di-GMP fluctuations is the diguanylate 
cyclase PleD, which is active in stalked but turned off in swarmer cells92. PleD is a response 
regulator, the activity of which is controlled by PleC and DivJ, the cell fate determinants that 
also regulate DivK phosphorylation levels during the cell cycle. Thus, PleD activity perfectly 
parallels the activation profile of DivK during the cell cycle27. In line with this, when peak levels 
of c-di-GMP are reached at the onset of S phase, the ligand directly binds to CckA to direct its 
kinase/phosphatase switch and to initiate chromosome replication10. In addition to CtrA 
dephosphorylation, c-di-GMP also triggers CtrA degradation by the ClpXP protease by binding 
to and activating the protease adaptor protein PopA104,156,202. Thus c-di-GMP acts at two 
independent levels to promote S phase entry by removing CtrA. 
Here we show that in addition to its key role in S-phase entry, c-di-GMP also orchestrates the 
G1/S specific gene expression program that leads to SpmX synthesis, DivJ activation and 
eventually DivK- and PleD-dependent CtrA inactivation. A combination of genetic and 
biochemical data revealed that c-di-GMP controls the ShkA-TacA pathway by directly binding 
to the ShkA sensor histidine kinase to strongly stimulate its kinase activity. Upon c-di-GMP 
mediated autophosphorylation, ShkA transfers phosphate to its C-terminal receiver domain 
from where it is passed on via the phosphotransfer protein ShpA to TacA, resulting in active 
TacA~P. We demonstrate that binding of c-di-GMP to a pseudo-receiver domain of ShkA, 
which is positioned between the kinase core and the receiver domain, alleviates ShkA auto-
inhibition leading to the activation of the ShkA-TacA pathway. We show that c-di-GMP-
mediated activation of ShkA and the subsequent c-di-GMP mediated proteolysis of ShkA 
together define a window of ShkA activity during the cell cycle. This window is sharpened to a 
narrow, G1/S specific period by TacA degradation, which precedes the degradation of ShkA. 
Thus, C. crescentus orchestrates G1/S specific gene expression in high temporal resolution 
through a combination of c-di-GMP mediated activation and degradation of ShkA-TacA 
phosphorylation components. Because ShkA binds c-di-GMP with higher affinity than CckA, the 
ShkA-mediated G1/S transcriptional network precedes the CckA switch leading to chromosome 
replication initiation as c-di-GMP levels are building up during the cell cycle. Together, these 
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results propose a model, where an upshift of c-di-GMP drives consecutive steps of the G1/S 
cell cycle progression in C. crescentus by sequentially activating hierarchized phosphorylation 
pathways. 
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5.1 C-DI-GMP CONTROLS THE SHKA-TACA PHOSPHORELAY 
A C. crescentus strain lacking all known or predicted diguanylate cyclases (referred to as cdG0 
strain in the following) shows severe developmental and morphological abnormalities87. Cells 
are elongated, irregularly shaped and lack all polar appendages including the stalk. Stalk 
biogenesis was recently shown to depend on an active ShkA-TacA phosphorelay. Moreover, 
shkA and tacA mutants show morphology and motility defects that partially phenocopy a cdG0 
strain. This opened the possibility that c-di-GMP controls C. crescentus growth and behavior by 
directly imposing control on the central ShkA-TacA regulatory pathway. To test this idea, we 
analyzed stalk biogenesis in the cdG0 strain expressing TacAD54E, a phospho-mimetic form of 
TacA174. In this strain stalk biogenesis was restored174. We analyzed ShkA-TacA activity in the 
cdG0 strain using a transcriptional lacZ reporter fusion to spmX, a TacA target gene involved in 
C. crescentus development and cell cycle progression133,151. While spmX transcription was 
greatly reduced in the cdG0, shkA and tacA strains, spmX promoter activity was restored in the 
presence of TacAD54E (Figure 5.1B). spmX transcription was also restored when c-di-GMP was 
provided in the cdG0 background or in a strain that lacks all DGC and PDEs (referred to as rcdG0 
strain) by IPTG-mediated expression of dgcZ from E. coli (Figure 5.2A). Thus, c-di-GMP itself 
and not a specific DGC of C. crescentus, drives spmX expression. In agreement with the 
transcription data we found that a SpmX-mCherry fusion fails to localize to the stalked pole in 
a shkA mutant and in the cdG0 strain. However, ectopic expression of TacAD54E rescued polar 
localization of a SpmX-mCherry fusion in the shkA and the cdG0 strain (Figure 5.1CFigure 
5.2D, C) and restored stalk biogenesis (Figure 5.2B).  
To corroborate the influence of c-di-GMP on ShkA-TacA activity, we sought to directly analyze 
phosphorylation of ShkA and TacA in vivo. Strains harboring chromosomally encoded TacA or 
ShkA with N-terminal 3xFLAG tags were examined using Phos-Tag PAGE and subsequent 
immunoblot analysis. In wild-type strains, FLAG-tagged ShkA or TacA migrated as two distinct 
bands, the upper one representing the phosphorylated species. In contrast, in strains lacking c-
di-GMP, both proteins were unphosphorylated but phosphorylation was restored by 
expressing the constitutively active DGC PleD*25 (Figure 5.1E). When c-di-GMP was gradually 
degraded in wild-type strains by overexpression of the heterologous PDE PA5295 from P. 
aeruginosa87, the phosphorylated forms of both TacA and ShkA disappeared over time (Figure 
5.1F).  
Altogether, these results provided strong evidence that c-di-GMP acts upstream of the ShkA-
TacA phosphorelay and that it is required for the activity of this pathway. 
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Figure 5.1: C-di-GMP controls the ShkA-TacA phosphorelay 
(A) The histidine kinase ShkA phosphorylates the phosphotransfer protein ShpA which in turn phosphorylates the 
response regulator and transcription factor TacA. TacA controls RpoN-dependent expression of downstream 
targets, including the lysozyme-like localization factor SpmX and the transcription factor StaR.  
(B) The expression of spmX is dependent on the ShkA-TacA pathway as well as on c-di-GMP levels. β-galactosidase 
assays were performed with the pPspmX-lacZ reporter plasmid. Promoter activity of spmX was measured in wild-type 
and mutant strains. Data represent mean ± SD. 
(C) The phospho-mimetic form of TacA, TacAD54E, restores stalk biogenesis and spmX-mCherry localization in the 
cdG0 strain. Microscopy of wild-type, cdG0 and ΔshkA strains that express a chromosomal spmX-mCherry fusion was 
performed. Both the cdG0 and the ΔshkA strains lacked stalk biogenesis and spmX-mCherry localization. Expressing 
tacA from the pPxyl::tacA plasmid did not affect these phenotypes. However, by expressing the phospho-mimetic 
mutant tacAD54E from the pPxyl::tacAD54E plasmid, both stalk biogenesis and spmX-localization were restored.  
(D) Evaluation of spmX-mCherry localization in the cdG0, ΔshkA and cdG0 ΔshkA strains. Only the wild-type 
background localizes spmX-mCherry and the expression plasmid pPxyl::tacA cannot restore localization. However, 
by expressing the plasmid containing the phospho-mimetic form pPxyl::tacAD54E, spmX-mCherry localized in all 
backgrounds. Increasing c-di-GMP levels by expressing the E. coli DGC dgcZ from the pPlac::dgcZ plasmid could only 
restore localization in the cdG0 strain.  
(E) Degrading c-di-GMP in wild-type strains by overexpression of the heterologous P. aeruginosa  PDE PA5295, 
phosphorylated forms of both FLAG-tagged ShkA and TacA disappeared over time. At indicated time points the 
expression plasmid pPQ5-PA5295 was induced with cumate. As a negative control, inactive PA5295AAL was expressed 
from the pPQ5-PA5295AAL plasmid. Lysates of exponentially growing cultures of wild-type strains with either N-
terminal FLAG-tagged TacA or N-terminal FLAG-tagged ShkA were run on Phos-Tag PAGE gels. Western blots were 
performed with α-FLAG antibodies.   
(F) Expressing a consitutively active pleD mutant (pleD*) in the cdG0 strain restored phosphorylation of FLAG-tagged 
ShkA and TacA. Wild-type and cdG0 strains with either N-terminal FLAG-tagged ShkA or N-terminal FLAG-tagged 
TacA were investigated for their phosphorylation levels. In each strain, c-di-GMP levels were complemented with 
the pPpleD-pleD* expression plasmid.  Lysates of exponentially growing cultures were run on Phos-Tag PAGE gels. 
Western blots were performed with α-FLAG antibodies.   
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Figure 5.2 C-di-GMP controls the ShkA-TacA phosphorelay 
(A) The expression of staR is dependent on the ShkA-TacA pathway as well as on c-di-GMP levels. β-galactosidase 
assays were performed with the pPstaR-lacZ reporter plasmid. Promoter activity of staR was measured in wild-type 
and mutant strains. Data represent mean ± SD. 
(B) Evaluation of stalk biogenesis in the cdG0, ΔshkA and cdG0 ΔshkA strains. Only in the wild-type background stalks 
are formed and the plasmid pPxyl::tacA cannot restore biogenesis. However, by expressing the plasmid containing 
the phospho-mimetic form pPxyl::tacAD54E, stalks were formed in all backgrounds. Increasing c-di-GMP levels by 
expressing the E. coli DGC dgcZ from the pPlac::dgcZ plasmid could only restore stalk formation in the cdG0 strain.  
(C) The phospho-mimetic form of TacA, TacAD54E, restores stalk biogenesis and spmX-mCherry localization in the 
cdG0 strain ΔshkA. The E. coli DGC dgcZ restores stalk biogenesis and spmX localization only in the cdG0 strain. 
Microscopy of wild-type, cdG0, ΔshkA and cdG0 ΔshkA strains that express a chromosomal spmX-mCherry fusion was 
performed. The cdG0, ΔshkA and cdG0 ΔshkA strains lacked stalk biogenesis and spmX-mCherry localization. 
Expressing tacA from the pPxyl::tacA plasmid did not affect these phenotypes. However, by expressing the 
phospho-mimetic mutant tacAD54E from the pPxyl::tacAD54E plasmid, both stalk biogenesis and spmX-localization 
were restored. Expressing the E. coli DGC dgcZ from the pPlac::dgcZ plasmid could only restore stalk biogenesis and 
spmX localization in the cdG0 strain. 
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5.2 C-DI-GMP STIMULATES SHKA KINASE ACTIVITY 
The above in vivo observations hinted at ShkA as the target of c-di-GMP. This was supported 
by a parallel unbiased approach that made use of Capture Mass Spectrometry (CCMS) to 
identify c-di-GMP effector proteins203. These experiments repeatedly identified ShkA as one of 
the top hits (Table 5.1).  
Table 5.1: ShkA identified by c-di-GMP capture compound mass spectrometry (CCMS) 
Protein Name ID CCMS experiment/CCMS competition1) 
    No of spectral counts of identified peptides 
Experiment No2)   1 2 3 4 
ShkA CC0138 2/0 3/1 3/0 6/0 
TipF CC0710 4/0 11/1 12/1 12/1 
PopA CC1842 20/4 32/9 20/6 36/10 
DGC3) CC0857 4/0 6/1 8/0 5/0 
 
1All competition experiments were performed in the presence of 1 mM c-di-GMP. 
2Experiment 1 and 2 were performed with 8µM c-di-GMP-CC, experiment 3 and 4 with 4µM c-di-GMP-
CC. 
3Unnamed C. crescentus diguanylate cyclase 
 
Isothermal titration calorimetry (ITC) revealed that ShkA indeed binds c-di-GMP with 
nanomolar affinity (KD 745 nM) (Figure 5.3, Figure 5.4). These results were reproduced 
qualitatively using UV-crosslinks with ShkA and P32-labelled c-di-GMP (Figure 5.7). In vitro 
phosphorylation experiments then demonstrated that c-di-GMP strongly stimulates the ShkA 
autokinase activity. This effect was highly specific, as none of the other nucleotides tested 
could stimulate ShkA (Figure 5.3).  
Earlier attempts using full-length ShkA protein had failed to show autophosphorylation 
activity. Autokinase activity was only observed, when the catalytic core of ShkA (including DHp, 
CA and REC1 domain) was separated from the C-terminal REC2 domain174. When recapitulating 
these experiments, ShkA autophosphorylation and phosphotransfer to TacA via ShkA-REC2 and 
ShpA was obtained irrespective of the presence of c-di-GMP (Figure 5.3). In contrast, when 
these experiments were carried out with full-length kinase, ShkA autophosphorylation and 
phosphotransfer to ShpA and TacA was readily observed, but only when c-di-GMP was added 
to the reactions (Figure 5.3). 
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In sum, we conclude that c-di-GMP directly binds to the ShkA kinase with high affinity and 
specificity to stimulate its autokinase activity and to promote phosphotransfer via ShpA to 
activate the response regulator TacA. 
 
 
Figure 5.3: C-di-GMP stimulates ShkA kinase activity 
(A) C-di-GMP specifically and exclusively stimulates ShkA phosphorylation. Multiple nucleotides were added to 
purified ShkA protein in different concentrations, 1000µM, 100µM and 10µM. Then [32P]ATP was added to 
determine ShkA activity. For positive controls 100µM c-di-GMP was added, for negative controls H2O.  
(B) C-di-GMP is needed to activate full length ShkA, while ShkA activity can be uncoupled from c-di-GMP by 
expressing its REC2 domain separately.  C-di-GMP or H2O was added to purified full length ShkA, ShpA and the 
receiver domain of TacA. Phosphorylation was then analyzed by adding [32P]ATP (left). The experiment was 
repeated by purifying the histidine kinase domain and the REC1 domain separately from the REC2 domain (right).  
(C) Isothermal titration calorimetry performed with ShkA and c-di-GMP yielded an average KD of 745 nM. Adding to 
12 μM ShkA in the cell, 130 μM c-di-GMP was injected in one 3µL step and 29 10µL steps. One measurement out of 
five is shown.  
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Figure 5.4: Isothermal titration calorimetry performed with ShkA and c-di-GMP yielded an average KD of 745 nM  
Adding to 12 μM ShkA in the cell, 130 μM c-di-GMP was injected in one 3µL step and 29 10µL steps. Four 
independent measurements are shown.  
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5.3 C-DI-GMP BINDING ALLEVIATES SHKA AUTO-INHIBITION 
Having identified ShkA as a target of c-di-GMP, we next sought to disclose the mechanism by 
which the ShkA kinase is activated. We reasoned that isolating c-di-GMP-independent ShkA 
mutants, i.e. ShkA variants that display kinase activity in the absence of c-di-GMP, would not 
only help to uncover the mechanism by which c-di-GMP activates ShkA, but would also provide 
an entry point into studying the role of this control during the C. crescentus cell cycle. We 
devised a genetic selection (see Materials and Methods) to isolate mutations in shkA that 
restored spmX expression in a rcdG0 strain. Four independent mutations (D369N, D369G, 
R371S and R371P) were identified in two nearby residues, D369 and R371, located in a short 
stretch of amino acids (referred to as “DDR” motif) in the linker region between REC1 and 
REC2 (Figure 5.5A). The DDR motif is conserved in ShkA orthologs from closely related 
Caulobacterales, including the orders Caulobacter, Asticcacaulis, Phenylobacterium and 
Brevundimonas, but is absent in ShkA orthologs of more distantly related Alphaproteobacteria 
(Figure 5.6). 
In the following studies, we focused on the D369N mutation, since this is the chemically most 
conservative among the substitutions found. Transduction into clean wild-type and rcdG0 
backgrounds followed by reporter assays confirmed that the shkAD369N allele restored spmX 
expression to wild-type levels in a rcdG0 strain (Figure 5.5D). Likewise, the shkAD369N allele 
restored in vivo phosphorylation of TacA or a stabilized version of TacA (TacADD, see below) in 
the cdG0 strain (Figure 5.5E). Together, this indicated that ShkAD369N kinase activity is 
uncoupled from its strict requirement for c-di-GMP. This was confirmed using purified 
ShkAD369N protein. ShkAD369N showed strong autophosphorylation activity even in the absence 
of c-di-GMP, although the mutant retained some c-di-GMP-mediated stimulation (Figure 
5.5B,C). This indicated that although kinase activity of the ShkAD369N variant was independent 
of c-di-GMP, this mutant was still able to bind c-di-GMP. This was confirmed by UV-crosslink 
experiments with 32P-labelled c-di-GMP demonstrating that the mutant protein binds c-di-GMP 
with wild-type-like affinity (Figure 5.5E). These results are also in line with in vivo data, 
demonstrating that the shkAD369N allele generates higher levels of spmX transcription in a strain 
producing c-di-GMP compared to the cdG0 background (Figure 5.5D). 
The above results identified the REC1-REC2 linker region as critical determinants of c-di-GMP-
mediated ShkA activation. In contrast, no such mutations were found in the neighboring REC2 
domain. This was surprising, since a previous study had found that ShkA lacking the REC2 
domain is competent for autophosphorylation in vitro174, irrespective of c-di-GMP, implying 
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that REC2 can inhibit autokinase function of the catalytic core. Based on this we reasoned that 
REC2 residues important for c-di-GMP mediated control may exist, but that they were 
impossible to be recovered in our genetic selection because of their essential nature for the 
phosphor-transfer function of REC2. To test this notion, we mutated the most strictly 
conserved acidic amino acids known to contribute to REC domain function in general44. In the 
case of ShkA REC2 these included E386 (mutated to Q) and D387 (mutated to N) being part of 
the magnesium binding pocket, the phosphoryl-acceptor D430 (mutated to N), and K480 
(mutated to R), involved in the stabilization of the D430-aspartyl moiety. All mutants showed 
autokinase activity irrespective of c-di-GMP (Figure 5.5F). 
Together, these data demonstrate that specific mutations in the REC1-REC2 linker region and 
in REC2 uncouple ShkA kinase activity from its strict requirement for c-di-GMP. These results 
outline a mechanistic model, in which the REC1-REC2 linker region together with conserved 
residues in the REC2 domain that are also critical for receiver domain function itself inhibit 
autokinase activity of ShkA.  
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Figure 5.5 Bypassing the dependence of ShkA autophosphorylation on c-di-GMP through mutations in the DDR 
motif and REC2 
(A) Schematic of ShkA domain architecture drawn to scale (top) and alignment of the REC1-REC2 linker harboring 
the DDR motif (highlighted in green) of ShkA orthologs from several Alphaproteobacteria (bottom). Ccr, C. 
crescentus; Cse, Caulobacter segnis; Che, Caulobacter henricii; K31, Caulobacter sp. K31; Pzu, Phenylobacterium 
zucineum; Abi; Asticcacaulis biprosthecium; Aex, Asticcaucaulis excentricus; Bsu, Brevundimonas subvibrioides.  
(B) In vitro autophosphorylation assays of ShkA and ShkAD369N. Reactions contained different concentrations of c-di-
GMP as indicated and autophosphorylation could proceed for 3.5 min at room temperature. Top: Autoradiograph; 
bottom: Coomassie stain of the same gel. 
(C) Time course of ShkAD369N autophosphorylation at 4°C with or without c-di-GMP. Top: Autoradiograph; bottom: 
Coomassie stain of the same gel. 
(D) β-Gal activities of indicated strains harboring the spmX’-‘lacZ fusion (plasmid pAK502-spmX). Shown are means 
and standard deviations of three biological replicates. 
(E) PhosTag PAGE western blots of strains harboring a 3xFLAG-tacA or 3xFLAG-tacADD fusion as indicated.  
(F) In vitro autophosphorylation assays of wild-type ShkA and indicated mutant variants with or without c-di-GMP. 
Autophosphorylation could proceed for 5 min at room temperature. Top: Autoradiograph; bottom: Coomassie stain 
of the same gel. 
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Figure 5.6 Phylogenetic analysis of ShkA orthologs and conservation of the DDR motif 
(A) Phylogenetic tree of ShkA orthologs. 
(B) Weblogo based on an alignment of ShkA orthologs within the Caulobacteraceae shown in (A). Circles below 
amino acid residues indicate residues that were mutated and tested for an effect on ShkA activity in vivo (red), were 
isolated as mutations that render ShkA activity c-di-GMP-independent (green), or were tested in vitro for their role 
in ShkA autoinhibition (orange). 
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5.4 C-DI-GMP BINDS TO THE SHKA REC1 PSEUDO-RECEIVER DOMAIN  
The isolation of a c-di-GMP-independent shkA allele offered a convenient way to screen for 
residues that were involved in c-di-GMP binding or c-di-GMP-mediated intramolecular signal 
transduction. The rationale was that any mutation in shkA that impaired kinase activity due to 
a specific defect in c-di-GMP binding or cdG-dependent activation should be rescued when 
combined with the D369N mutation, while other, more general kinase defects would not be 
recuperated. For this analysis we mainly focused on Arg residues and on aromatic and acidic 
amino acids as they represent key determinants of c-di-GMP binding sites204. An alignment of 
ShkA orthologs from C. crescentus and related organisms revealed several candidate residues 
for c-di-GMP binding (Figure 5.7A). Single or double point mutations of candidate residues 
were engineered in shkA on a low-copy number plasmid and introduced into a shkA strain 
harboring a spmX-lacZ reporter to assay ShkA activity. Residues that are generally conserved in 
histidine kinase activity (H-, N-, G1-, G2- and F-boxes) or in receiver domain function (REC2) 
were not considered. However, because the REC1 domain is a pseudo-receiver domain lacking 
the acidic magnesium-binding pocket, we tested some of the REC1 residues that are normally 
important for receiver domain function. A D430N substitution that eliminates the Asp 
phosphoryl-acceptor of REC2 was included as a negative control. 
Mutations that affected ShkA kinase activity in vivo were found in the kinase catalytic core 
(DHp and CA domains) and the REC1 domain, but not in REC2 (Figure 5.7A). The most severe 
effects were observed for the F230A/F234A double substitutions in the CA domain and the 
R324A and Y338A single substitutions in the REC1 domain (Figure 5.7B). Next we focused on 
mutations that resulted in less than 50% of wild-type activity and combined them with the 
D369N mutation conferring c-di-GMP independence. Except for the F230/F234A substitutions, 
introduction of D369N restored spmX-lacZ activity to wild-type levels in all cases, indicating a 
functional role of these residues in c-di-GMP-mediated ShkA activation (Figure 5.7C). Binding 
assays with purified ShkA variants and radiolabeled c-di-GMP identified several mutants with 
reduced binding (Figure 5.7E). The strongest reduction in binding affinity was observed for 
ShkA with the Y338A mutation, implying a direct role of this residue in c-di-GMP binding 
(Figure 5.7E). Congruent with these binding studies and with in vivo results (above), both 
R324A and Y338A variants were inactive both in the presence and absence of c-di-GMP, but 
were competent for autophosphorylation when combined with the D369N mutation (Figure 
5.7D). In agreement with their binding affinities (Figure 5.7E), the R324A mutation largely 
retained stimulation by c-di-GMP when combined with D369N, while the Y338A variant 
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displayed only marginal stimulation by c-di-GMP (Figure 5.7D). We next asked whether REC1 
alone was sufficient to bind c-di-GMP. To this end, the purified REC1 domain was subjected to 
UV crosslinking experiments with radiolabeled c-di-GMP and was indeed found to strongly 
bind c-di-GMP (Figure 5.7F). Altogether, these experiments exposed the REC1 pseudo-receiver 
domain of ShkA as the primary docking site for c-di-GMP and identified candidate residues for 
c-di-GMP binding. 
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Figure 5.7 A degenerate REC domain is the primary c-di-GMP docking site in ShkA 
(A) Schematic of ShkA domain architecture drawn to scale (top). Number below the schematic indicate domain 
boundaries. Residues that were mutagenized and tested in vivo are indicated above the schematic. Residues that 
when mutated impair c-di-GMP-dependent ShkA autophosphorylation are highlighted in red. The phosphorylatable 
His and Asp residues in the DHp and REC2 domain, respectively, are indicated by an asterisk. Weblogos (based on 
alignments shown in Figure 5.6) of selected regions that harbor amino acids implicated in c-di-GMP-dependent 
activation (indicated by a red dot) are shown at the bottom. Residues that were mutagenized and tested, but 
showed no adverse effects ShkA activity in vivo are indicated by a white circle. 
(B) β-Gal activities a strain ((ΔshkA ΔlacA::/ pAK502-spmX; UJ9691) expressing indicated shkA alleles in trans from 
plasmid pQF (no inducer added). Shown are means and standard deviations of three biological replicates. 
(C) β-Gal activities a strain (ΔshkA ΔlacA::/ pAK502-spmX; UJ9691) expressing shkA alleles with indicated amino 
acid substitutions in isolation (shkAWT BG) or in combination with the D369N substitution (shkAD369N BG). Note that 
the values shown for the shkAWT BG are the same as in (B). Shown are means and standard deviations of three 
biological replicates. 
(D) In vitro autophosphorylation assays of wild-type ShkA and indicated mutant variants with (10µM) or without c-
di-GMP. Autophosphorylation was allowed to proceed for 5 min at room temperature. Top: Autoradiograph; 
bottom: Coomassie stain of the same gel. 
(E) Quantification of in vitro UV crosslinking experiments with 32P-labelled c-di-GMP and indicated ShkA variants. 
(F) In vitro UV crosslinking experiments with 32P-labelled c-di-GMP (10µM) and full-length ShkA or the isolated REC1 
domain of ShkA. For competition, a 100-fold molar excess of unlabeled c-di-GMP was added to the reaction mix 
before UV crosslinking. The asterisk indicates a radiolabeled background smear. 
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Figure 5.8 c-di-GMP-independent activation of ShkA restores morphological and cell cycle defects of a strain 
lacking c-di-GMP. 
(A) Phase contrast micrographs of indicated strains. Arrows point to stalks. The scale bar represents 4µm. 
(B) Quantification of cell length of strains shown in (A). The median with interquartile range is shown and the means 
+/- standard deviations are indicated above the graph (in µm). Cell detection was performed with Oufti. 
(C) Sensitivity of indicated strains towards phage CbK or CR30 infection. Plates were incubated 24h at 30°C. 
(D) Motility of indicated strains on semi-solid agar. Plates were incubated 3 days at 30°C. 
(E) DivJ-mCherry localization in indicated strains. Shown are merges between the phase contrast channel and the 
mCherry channel. The scale bar represents 4µm. 
(F) Volcano plot comparing the proteomes of the rcdG0 strain and its derivative carrying the shkAD369N allele. 
Selected proteins that are differentially abundant in the two strains with high confidence and fold-change are 
labelled by the NA1000 CCNA_ number. 
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5.5 C-DI-GMP-MEDIATED ACTIVATION AND PROTEOLYSIS DEFINES THE SHKA-TACA 
ACTIVITY WINDOW DURING THE CELL CYCLE 
C-di-GMP regulates several processes during the C. crescentus cell cycle including cell polarity 
or the initiation of chromosome replication during G1/S transition10,87,165. However, how 
individual pathways contribute to the pleiotropic phenotype of the cdG0 strain remained 
unclear. Introduction of the c-di-GMP independent shkAD369N allele into the rcdG0 strain failed 
to re-establish motility or functional type IV pili, but restored stalk biogenesis and normal cell 
morphology (Figure 5.8). The latter observation suggested that ShkA-TacA is an integral part of 
the machinery regulating C. crescentus cell cycle progression. Recent studies had implicated 
the ShkA-TacA pathway in the SpmX-mediated polar localization and activation of the cell cycle 
kinase DivJ during G1/S transition151. In line with the above results, a DivJ-mCherry fusion, 
while completely delocalized in the cdG0 strain, localized normally in the presence of the 
shkAD369N allele, a process that was fully dependent on the TacA target spmX (Figure 5.8). 
Moreover, rescue of normal cell morphology by the shkAD369N allele also depended on spmX 
(Figure 5.8). Proteome analysis indicated that shkAD369N indeed restored the expression of 
known TacA targets in the rcdG0 background, including SpmX and StaR (Figure 5.8). Thus, 
aberrant cell division of the cdG0 strain is caused largely by an inactive ShkA-TacA pathway and 
by the failure to induce the expression of the SpmX morphogen during G1/S. 
Levels of c-di-GMP oscillate during the cell cycle27,86. While being low in newborn SW cells (G1), 
c-di-GMP rapidly increases during the G1/S transition to reach peak levels upon entry into S-
phase87 (Figure 5.9A). The finding that c-di-GMP activates ShkA, together with the recent 
observation that TacA is rapidly degraded upon entry of cells into S-phase70,156, argued that the 
ShkA-TacA pathway is tightly controlled during the cell cycle with a sharp peak of activity 
during G1/S. The analysis of TacA phosphorylation during the cell cycle revealed that active 
TacA~P was limited to a narrow window during G1/S (Figure 5.9B). As expected, TacA was 
rapidly degraded prior to S-phase entry and re-synthesized, but not phosphorylated, in G2 
(Figure 5.9B). Degradation of TacA by the ClpXP protease required the adaptor proteins RcdA 
and CpdR (Figure 5.9C). When TacA was stabilized by replacing the C-terminal Ala-Gly 
degradation motif with Asp residues (TacADD) both TacA and TacA~P prevailed during the 
entire cell cycle (Figure 5.9B). This argued that degradation of TacA limits the cell cycle window 
during which TacA is active.  
Akin to TacA~P, phosphorylated ShkA, ShkA~P, was only detected in G1 (Figure 5.9B). Both 
TacA~P and ShkA~P levels were detected immediately after harvesting a pure population of G1 
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swarmer cells by density gradient centrifugation (see Materials and Methods). Because the 
synchronization technique harvests all high-density swarmer cells irrespective of their exact 
age after division, ShkA~P and TacA~P levels represent population averages rather than exact 
values corresponding to a distinct cell cycle stage87. Moreover, because sample preparation 
includes a short period of temperature equilibration, phosphorylation levels at the first 
sampling point are likely overestimated as a subset of the population has already increased c-
di-GMP levels. Surprisingly, ShkA was also degraded during the cell cycle, although with a delay 
of about 20 minutes as compared to TacA (Figure 5.9B). This delay was explained by the 
finding that, in contrast to TacA degradation, which depends on CpdR and RcdA, degradation 
of ShkA also requires PopA, the third member of the adaptor hierarchy regulating ClpXP-
dependent degradation during the C. crescentus cell cycle (Figure 5.9D)156. ShkA also harbors a 
C-terminal Ala-Gly degradation motif, which when replaced by Asp residues (ShkADD) lead to 
stable ShkA protein and to an extended ShkA activity window during the cell cycle, as ShkA~P 
levels also prevailed (Figure 5.9D).  
Based on these observations, we proposed that the ShkA-TacA activity is confined to the G1/S 
transition by sequential c-di-GMP mediated activation of the ShkA kinase and ClpXP-
dependent degradation of both TacA and ShkA. While activation of TacA target genes during 
G1/S facilitates “just-in-time” expression of genes required for the next stage of the cell cycle 
or development, it is less clear why the ShkA-TacA pathway is confined to such a narrow 
window by specific proteolysis of its key components. To simulate a ShkA-TacA pathway that 
remains constitutively active throughout the cell cycle and to investigate the consequences of 
such dysregulation, alleles leading to constitutive activity and/or stability of ShkA and TacA 
were assembled in different combinations. As shown in Figure 5.9E and F, cell division and 
morphology remained wild-type-like in all strains that retained either TacA degradation or 
ShkA control. Combining TacADD either with ShkADD or with ShkAD369N in the same strain led to a 
significant increase of cell length, which was aggravated in a strain that contained all three 
mutations. Importantly, the severe morphology defect in cells with a dysregulated ShkA-TacA 
pathway was entirely dependent on an intact copy of spmX, arguing that the observed defect 
is due to misregulation of the SpmX morphogen. Thus, these experiments confirmed that not 
only the timing of ShkA-TacA activation is important but also its exact window of activity. This 
provides the rationale for the highly sophisticated regulatory mechanisms that are in place to 
limiting TacA-dependent transcription to a short phase of the cell cycle. 
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Figure 5.9 Precise ShkA-TacA activation by phosphorylation and shut-down by degradation ensure proper cell 
cycle progression and morphogenesis. 
(A) Scheme of c-di-GMP oscillations during the cell cycle. 
(B) PhosTag PAGE western blots of synchronized cultures of strains carrying 3xFLAG-tagged tacA or shkA or their 
stabilized derivatives, tacADD or shkADD. 
(C) PhosTag PAGE western blots of mixed cultures of various mutant strains carrying 3xFLAG-tagged tacA. A boiled 
sample was included to specifically deplete the phosphorylated protein band. 
(D) PhosTag PAGE western blots of mixed cultures of various mutant strains carrying 3xFLAG-tagged shkA. A boiled 
sample was included to specifically deplete the phosphorylated protein band. 
(E) Phase contrast micrographs of strains that carry combinations of alleles encoding TacA or ShkA variants blocked 
for degradation (DD) and/or ShkA carrying the constitutively active, c-di-GMP independent D369N mutation (DN). 
The scale bar represents 4µM. 
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(F) Quantification of cell length of strains shown in (E). The median with interquartile range is shown and the means 
+/- standard deviations are indicated above the graph (in µm). Cell detection was performed with Oufti and 
statistical analysis with GraphPad Prism 7 on 480-489 random cells for each strain using the Kruskal-Wallis test. 
*,**,*** and **** indicate P values of < 0.1, <0.01, <0.001 and <0.0001, respectively; ns, not significant. 
(G) The expression of spmX can be increased by stabilizing proteins in the ShkA-TacA pathway as well as expressing 
constitutively active ShkAD369N. β-galactosidase assays performed with the pPspmX-lacZ reporter plasmid. Promoter 
activity of spmX was measured in wild-type and mutant strains. Data represent mean ± SD. 
5.6 THE SHKA-TACA PATHWAY LIMITS GENE EXPRESSION TO G1/S  
To visualize TacA activity in individual cells progressing through the cell cycle and to validate 
the G1/S specific expression profile of TacA target genes, we developed a fluorescent reporter 
system, in which we fused the spmX promoter to the photoconvertible fluorescent protein 
dendra2. This reporter is capable of photoconversion from green to red fluorescence in 
response to UV light205 and thus allows to distinguish old red reporter from newly synthesized 
green reporter. Photoconversion at different time points during a specific time window 
provides information regarding both ON and OFF kinetics of transcription. When predivisional 
cells expressing a spmX::dendra2 promoter fusion were followed through the division process 
after photoconversion, increase of green fluorescence und thus spmX promoter activity was 
only observed in the SW but not in the ST progenies (Figure 5.10A). Quantification of SW 
offspring over time indicated transcription of spmX is activated 15-30 min after 
photoconversion (Figure 5.10B). Next, we performed a similar experiment but applied 
photoconversion at different time points during the G1/S transition to determine the OFF 
kinetics of the spmX promoter (Figure 5.10B). Matching the data from both experiments 
revealed that transcription of spmX peaks about 15-30 minutes after cells had reached the 
predivisional stage (Figure 5.10B). For several reasons, the actual response time of spmX 
transcription after birth is likely shorter. First, because exact monitoring of cell division is 
difficult, photoconversion was generally applied prior to division. Second, for microscopy cells 
were cultivated on agar pads reducing their growth rate as compared to cells grown in liquid 
(Figure 5.10A,E). Finally, folding of the reporter sets off fluorescence appearance from the time 
of gene expression. 
To verify that the spmX promoter is transcribed exclusively during G1/S and to probe the role 
of c-di-GMP and the ShkA-TacA pathway in spmX gene expression control, the spmX-dendra2 
reporter output was monitored in individual cells and during three consecutive cell divisions. 
The analysis of individual lineages revealed that in a C. crescentus wild type strain reporter 
activity was only detected in cells progressing through G1/S, while it was absent in ST progeny 
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(Figure 5.10D, Figure 5.11). This stage-specific pattern is in part due to c-di-GMP oscillations 
during the cell cycle as expression of the E. coli DGC dgcZ from the constitutive Plac promoter 
induced spmX transcription in ST progeny lineages (Figure 5.10D, Figure 5.11). Similarly, in 
lineages of cells expressing a stable version of TacA (TacADD), the strong preference for G1/S 
expression was abolished. Finally, expression patterns lost stage-specificity completely in all 
lineages co-expressing TacADD and dgcZ or expressing TacADD together with the constitutive 
ShkA variant, ShkAD369N (Figure 5.10C,D, Figure 5.11). 
Altogether, these experiments provide direct evidence that the activity of the ShkA-TacA 
pathway is strictly limited to swarmer progeny going through the G1/S cell cycle transition. 
Moreover, these experiments on a single cell level confirm data obtained with synchronized 
populations of cells indicating that the strict temporal control of ShkA-TacA activity during the 
cell cycle results from a combination of c-di-GMP-mediated kinase activation and protein 
degradation.  
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Figure 5.10 TacA activity is limited to the G1-S transition and strictly dependent on c-di-GMP oscillations, ShkA 
activation and TacA degradation 
TacA activity is deduced by the timing of spmX promoter activity visualized using a promoter fusion to the 
fluorescent reporter dendra2. In contrast to the wild type, strains with increased c-di-GMP levels, producing 
degradation-independent TacA as well as c-di-GMP-independent hyper-active ShkA shift this activity window.  
Lineages of cells were analyzed originating from the same parental PD, this late PD was used as a reference time-
point to determine cell septation before motile and swarmer cells were analyzed over the course of the cell cycle. 
The last time-point marks the last frame before the cell septation. During time-lapse imaging frames were taken 
every 15 minutes. Time-point zero refers to the first frame after septation of the two cells. Unless stated otherwise 
the green fluorescence of PD cells was switched to red 15 minutes before division using UV light (DAPI) and the 
increase of newly synthesised dendra2 (green fluorescence) was determined over time in various genetic 
backgrounds. PspmX activity is shown in green, absence in gray. Abbreviations: ST = stalked cells, SW = swarmer 
cells, PD = predivisional cell. 
(A) PspmX activity rises sharply in wild-type swarmer cells but remains absent in stalked cells. Fluorescence of the 
offspring of 39 PDs was plotted over one cell cycle. 
(B) The window of TacA activity follows the G1-S transition between 15 to 30 minutes after septation as inferred 
from the ON and OFF kinetics in wild-type swarmer cells. For up-kinetics, 39 PD cells were switched 15 minutes 
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before division using UV light and the time of the increase of fluorescence in the swarmer population. For down 
kinetics, 80 cells at different stages during the cell cycle were switched using UV light and the increase of 
fluorescence was determined using the time-point after septation as reference time-point zero. Ratio of cells with 
PspmX activity was plotted over time. 
(C) Increased c-di-GMP levels and c-di-GMP-independent hyper-active ShkAD369N increase the probability that 
swarmer cells activate the spmX promoter just after septation and thereby spmX activity is preponed. Inferred ON 
kinetics of wild-type compared to different mutant strains, between 10-39 PD cells just before division were 
switched using UV light and the increase of fluorescence was determined over time. Ratio of cells with spmX activity 
was plotted over time. 
(D) As soon as c-di-GMP levels are not oscillating, TacA degradation is perturbed and ShkA is hyper-active, spmX 
activity is switched on in stalked cells and increases dramatically. Cell fluorescence of 10-40 cells was measured over 
the cell cycle of swarmer and stalked cells of wild-type and various mutant strains. The inlay graph shows the 
fraction of swarmer/stalked cells scored with PspmX active (green) or inactive (gray).  
(E) Preliminary microfluidic experiments reinstate the delay of rising spmX promoter activity after division towards 
G1-S phase transition. Cells were allowed to grow and attach in microfluidic chambers subjected to constant flow of 
0.002µl/s. 
  
52 | Results 
 
 
Figure 5.11 The oscillation of spmX activity is dependent on a functional ShkA-TacA pathway and oscillating c-di-
GMP levels. 
During three consecutive generations starting of at least 10 PD only G1-S-cells in wild-type show oscillating spmX 
activity. As soon as c-di-GMP levels are not oscillating, TacA degradation is perturbed and ShkA is hyper-active, the 
spmX promoter is constitutively more active in all cell types. Plotted is the fraction of cells with PspmX active 
(green) or inactive (gray).  
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6 DISCUSSION & OUTLOOK 
In recent years, we have gained a deep understanding of how the bacterial model organism C. 
crescentus coordinates cell division with morphological and behavioral changes. C. crescentus 
divides asymmetrically to produce a replication competent ST and a replication-inert SW cell. 
After a defined period (called G1) the motile SW cell regains its replicative potential and enters 
S-phase, a process during which it also differentiates into a sessile ST cell. Three regulatory 
mechanisms orchestrate the unidirectional G1-S transition in parallel: A complex 
phosphorylation network of two-component systems promotes cell cycle progression; 
controlled proteolysis removes key G1 components to advance the cell cycle irreversibly; and 
rising levels of c-di-GMP coordinate morphogenesis with the underlying cell cycle. However, 
the details of how these mechanisms are interlinked have remained incomplete.  
A C. crescentus strain that lacks all diguanylate cyclases (cdG0) and therefore cannot produce c-
di-GMP has severe division defects and expresses no polar appendages87. Adding to these 
phenotypes, we could show that neither ShkA nor TacA are phosphorylated in this background. 
Intriguingly, when we expressed a constitutively active tacAD54E mutant in the cdG0 background 
to simulate and activate the ShkA-TacA pathway, not only spmX expression was rescued, but 
also stalk biogenesis. In addition, c-di-GMP was sufficient to induce phosphorylation of both 
ShkA and TacA in vivo. This evidence suggested that this pathway is part of the transcriptional 
network orchestrating cell cycle progression and that its activity is controlled by the c-di-GMP 
upshift during this transition. 
By showing in vitro that c-di-GMP not only binds to ShkA strongly but also stimulates its 
phosphorylation activity, we could establish a direct link between the ShkA-TacA pathway and 
c-di-GMP phenotypes. Counterintuitively, ShkA does neither have a classical c-di-GMP binding 
motif nor an input domain. However, the protein contains two receiver domains, one of them, 
REC1, lacking residues important for phosphorylation. In a genetic screen, we found a highly 
conserved, short stretch of amino acids (DDR motif). When we mutated residues in this motif, 
for example D369N, ShkA phosphorylation was released from its c-di-GMP control. 
By expressing this c-di-GMP independent shkAD369N allele in the cdG0 background, we could 
restore cell morphology and stalk biogenesis. However, phenotypes linked to motile SW cells 
including pili biogenesis and motility stayed impaired. The fact that ShkAD369N only restored 
phenotypes directly linked to G1-to-S phase transition, suggested that the ShkA-TacA pathway 
is linked to this phase in dependence of c-di-GMP.  
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In a ShkAD369N mutation that is active independently of c-di-GMP, binding itself was not 
obliterated. This allowed us to track residues that are likely involved in binding c-di-GMP. 
Mutating the still conserved tyrosine switch residue in the nonfunctional REC1 domain, Y338A, 
reduced binding to c-di-GMP strongly. In addition, autokinase activity of ShkA was turned off 
even in the presence of c-di-GMP. However, by introducing the D369N mutation, autokinase 
activity was restored. This strongly suggests, that Y338 is involved in c-di-GMP binding to 
control kinase activity. Upon the phosphorylation of a functional receiver domain, the switch 
residue generally initiates a conformational change45. As the REC1 of ShkA cannot be 
phosphorylated, it is possible that c-di-GMP binding induces a conformational change instead 
(Figure 6.1).  
ShkA is active in vitro when the REC2 domain is expressed separately even in the absence of c-
di-GMP. This loss of inhibition indicates, that the REC1 usually prevents phosphorylation to 
take place by coordinating the other domains of ShkA into an inhibitory conformation. 
Mutating the phosphorylation site or residues in the magnesium binding pocket of the REC2 
domain impaired phosphotransfer but restored autokinase activity. This indicates that the 
REC2 domain itself is also involved in kinase regulation. A conformational change initiated by c-
di-GMP might therefore free the domains to initiate autophosphorylation and 
phosphotransfer. Solving the protein structure of ShkA will help us describe the mechanistic 
details of this novel regulatory kinase mechanism at a later stage.  
Our data suggests, that the c-di-GMP regulation of ShkA must work differently to another C. 
crescentus histidine kinase also under the control of c-di-GMP. It was recently shown, that c-di-
GMP forces the histidine kinase CckA from a kinase into a phosphatase. C-di-GMP thereby 
binds to the DHp domain and forces CckA into an open conformation that allows its receiver 
domain access for dephosphorylation29. While this means that c-di-GMP directly binds to the 
CckA DHp domain to switch it from a kinase to a phosphatase, ShkA binds c-di-GMP in its 
pseudo receiver domain which activates kinase activity.   
As the DDR motif that couples c-di-GMP regulation to kinase activity is conserved in ShkA 
orthologs of Caulobacteraceae, it would be exciting to test whether these are also under 
control of c-di-GMP or if they are regulated differently. ShkA is a determining factor in 
regulating the lifestyle of C. crescentus and might have similar functions in other bacteria. 
However, adapting to different ecological niches might also require another regulation of 
ShkA.  
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Intriguingly, many kinases exist with two receiver domains. In these kinases, one of the 
receiver domains may also perform regulatory functions. This means that similar mechanisms 
to control kinase activity may be widespread in bacteria. 
 
Figure 6.1: Without c-di-GMP, the histidine kinase ShkA cannot autophosphorylate (H23) or phosphotransfer (D430) 
to REC2. After c-di-GMP binds to the switch residue Y338, autophosphorylation and phosphotransfer is activated. 
Residues that are involved in ShkA activity are indicated. Based on data from Figure 5.7. 
In the C. crescentus cell cycle, both TacA and ShkA are specifically degraded by ClpXP adaptors. 
It was shown before, that TacA degradation is dependent on the adaptors RcdA and CpdR156. 
Adding to that, we showed that ShkA is degraded in a 20-minute delay by the third adaptor 
PopA in a c-di-GMP dependent manner.  Both proteins are phosphorylated early in the cell 
cycle what coincides with a rise of c-di-GMP levels early in G1-to-S phase transition87. As ShkA 
phosphorylation is activated by c-di-GMP, we reasoned that its activity is dependent on a 
certain threshold of emerging c-di-GMP levels, while the pathway later is turned off by protein 
degradation.  
To assess how c-di-GMP levels and protein degradation influence pathway activity, we 
performed experiments on a single cell level with fluorescence reporters. This allowed us to 
measure and compare up- and down-kinetics of a spmX::dendra2 promoter fusion. With this 
assay, we could demonstrate, that spmX expression is indeed limited to G1-to-S phase 
transition with no expression in S-phase. However, this specific expression window was lost 
when the E. coli diguanylate cyclase dgcZ was expressed, or when the pathway was uncoupled 
from c-di-GMP control by expressing shkAD369N. The clear pattern of spmX expression could 
also be abolished on an output level. When we impaired degradation of the pathway 
components TacA or ShkA by stabilizing them, spmX expression was active in all cell stages.  
Taken together, these data demonstrate that spmX expression is limited to G1-S phase by 
activation of ShkA by rising c-di-GMP levels and deactivation by degrading of TacA. By 
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regulating the ShkA-TacA pathway on an input level as well as on an output level, it can be 
delicately controlled. Early in G1-toS phase transition, ShkA phosphorylation is activated in 
dependence of c-di-GMP.  Then, proteolysis sharply turns off the pathway by degrading TacA 
and later ShkA. This pathway regulation is necessary, as impairing proteolysis of ShkA and TacA 
and uncoupling ShkA activity from c-di-GMP leads to severe division defects, most likely due to 
a misregulation of SpmX (Figure 6.2).  
Based on our findings, we can answer the outstanding question of how G1-to-S phase 
transition is regulated in C. crescentus. Kinase activity and proteolysis drive the C. crescentus 
G1-to-S phase transition. However, this process is under the control of c-di-GMP in a highly 
regulated and tightly timed fashion. Rising levels of c-di-GMP in the SW cell successively 
activate cell cycle checkpoints: First emerging levels of c-di-GMP likely activate ShkA 
phosphorylation to express spmX. SpmX localizes and stimulates DivJ kinase activity. DivJ then 
phosphorylates the diguanylate cyclase PleD which initiates a feedback loop to quickly rise c-
di-GMP levels in the cell. In addition, DivJ together with DivK~P and c-di-GMP turns off the 
CckA-Chpt-CtrA pathway by switching CckA into phosphatase mode and allowing the cell to 
start replication. Switching CckA into a phosphatase also activates the first ClpXP adaptor CpdR 
to activate proteolysis of the phosphodiesterase PdeA, allowing c-di-GMP levels to rise even 
higher. During this time, TacA is also acting as a transcription factor for staR and thereby has 
initiated stalk biogenesis and holdfast production. The protease adaptor RcdA then binds to 
the ClpXP-CpdR complex to degrade TacA. This turns off the ShkA-TacA switch, defining a close 
window in which this pathway is active and provides the SW cell with what it needs to turn 
into a ST cell. Finally, c-di-GMP reaches peak levels to activate the last ClpXP adapter PopA to 
degrade CtrA and ShkA. This largely completes G1-to-S phase transition.  
Taken together, we show that the second messenger c-di-GMP defines and controls the entire 
G1-to-S phase transition in C. crescentus. Rising levels of c-di-GMP progressively trigger cell 
cycle checkpoints by activating kinase pathways. Additionally, c-di-GMP helps to enforce 
unidirectional cell cycle progression by controlling proteolysis. C-di-GMP therefore elegantly 
orchestrates and integrates the complex networks of G1-to-S phase transition. 
Due to the immense complexity of the C. crescentus G1-to-S phase transition, open questions 
remain. While TacA is degraded early by RcdA, ShkA is degraded later by PopA. This could 
mean that the ShkA-ShpA pathway branches off and controls more than only TacA activity. 
More importantly, it is not clear what initially triggers the G1-to-S phase transition. DivJ and 
PleC are important to start the cell cycle by phosphorylating DivK. However, a ΔdivJ ΔpleC 
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double mutant is viable, while a ΔdivK mutant is lethal. As DivK does not have domains that 
allow autophosphorylation, there could be additional kinases activating DivK.  
Very early in G1-to-S phase transition, ShkA activity needs to be upregulated by emerging 
levels of c-di-GMP to initiate the c-di-GMP feedback loop. It would seem natural that one of 
the many diguanylate cyclases in C. crescentus with unknown function and regulation could be 
responsible for this initial push. PleC most likely plays an important role in regulating this 
process, as no spmX expression remains in a ΔpleC strain, however it is still unclear how the 
initial push into cell division is regulated. Solving the open questions of how C. crescentus cell 
division is initiated will most likely expand our knowledge on this complex regulatory network 
even further.   
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Figure 6.2: G1-to-S phase transition. Pathway activity of ShkA and TacA is defined by rising c-di-GMP levels that 
induce ShkA kinase, and protein degradation by ClpXP adaptors. TacA is degraded early by RcdA. This leads to a 
short activity window of the ShkA-TacA pathway. ShkA is degraded by PopA at a later stage to possibly 
phosphorylate other targets.  
 
  Material & Methods | 59 
7 MATERIAL & METHODS 
7.1 STRAINS USED IN THIS STUDY 
For E. coli, recombinant DNA techniques and procedures for DNA purification, restriction, 
ligation and transformation were performed as described before206. For C. crescentus, bi-
parental conjugation with E. coli S17-S, tri-parental conjugation with E. coli DH10b and an E. 
coli donor strain with the RP4 plasmid, or transduction with фCR30 phage was carried out as 
described before207. Restriction enzymes were obtained from New England Biolabs (NEB) 
and PCR reactions were performed with Phusion polymerase (NEB). Oligonucleotides were 
purchased from Sigma-Aldrich. All constructs were sequence verified. 




BL21 Rosetta Novagen 
 
DH10B Life Technologies 
 
DH5a Woodcock et al. 1989 
 
S17 Simon et al. 1983 
 
MT607 Vargas et al. 1999 
   
C. crescentus   
UJ4475 NA1000 (wild-type strain, synchronizable, CB15N) Evinger & Agabian, 1977 
AKS1 CB15 rcdG0 ΔlacA::W ampG::pNPTStet-ampG Kaczmarczyk, A. 
AKS4 CB15 rcdG0 ΔlacA::W Kaczmarczyk, A. 
AKS17 CB15 rcdG0 ΔlacA::W/pAK502-spmX Kaczmarczyk, A. 
AKS30 CB15 rcdG0 ΔlacA::W shkA(D369N)/pAK502-spmX Kaczmarczyk, A. 
AKS102 NA1000 ΔspmX::pNPTSDspmX Kaczmarczyk, A. 
AKS118 NA1000 ΔspmX Kaczmarczyk, A. 
AKS121 NA1000 rcdG0 shkA(D369N) DspmX Kaczmarczyk, A. 
AKS152 NA1000 divJ::mCherry Kaczmarczyk, A. 
AKS153 NA1000 rcdG0 divJ::mCherry Kaczmarczyk, A. 
AKS154 NA1000 rcdG0 shkA(D369N) divJ::mCherry Kaczmarczyk, A. 
AKS155 NA1000 ΔspmX divJ::mCherry Kaczmarczyk, A. 
AKS156 NA1000 rcdG0 shkA(D369N) DspmX divJ::mCherry Kaczmarczyk, A. 
AKS181 NA1000 ΔshkA divJ::mCherry Kaczmarczyk, A. 
AKS182 NA1000 tacA(A491D,G492D)::pNPTS-tacADD Kaczmarczyk, A. 
AKS216 NA1000 rcdG0 ΔshkA Kaczmarczyk, A. 
AKS217 NA1000 shkA(D369N,A513D,G514D) tacA(A491D,G492D) Kaczmarczyk, A. 
AKS236 
NA1000 shkA(D369N,A513D,G514D) tacA(A491D,G492D) 
ΔspmX 
Kaczmarczyk, A. 
AKS237 NA1000 ΔpleC shkA(D369N) Kaczmarczyk, A. 
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AKS255 NA1000 ΔpleC shkA(D369N) divJ::mCherry Kaczmarczyk, A. 
AKS256 NA1000 ΔpleC divJ::mCherry Kaczmarczyk, A. 
AKS257 NA1000 shkA(D369N) divJ::mCherry Kaczmarczyk, A. 
UJ6168 CB15 ΔlacA::W Arellano et al., 2010 
UJ9652 NA1000 ΔshkA ΔlacA::W Kaczmarczyk, A. 
AKS147 NA1000 ΔshkA::pNPTSDshkA ΔlacA::W Kaczmarczyk, A. 
UJ5065 NA1000 cdG0 Abel et al., 2013 
UJ9056 NA1000 ΔshkA von Arx, C. 
CvA32 NA1000 cdG0 ΔshkA  von Arx, C. 
CvA03 NA1000 spmX-mCherry von Arx, C. 
CvA04 NA1000 cdG0 spmX-mCherry von Arx, C. 
CvA06 NA1000 ΔshkA spmX-mCherry von Arx, C. 
CvA50 NA1000 cdG0 ΔshkA spmX-mCherry von Arx, C. 
UJ8535 NA1000 3xFlag-shkA von Arx, C. 
UJ8536 NA1000 3xFlag-shkA cdG0 von Arx, C. 
UJ8959 NA1000 3xFlag-shkA r-cdG0 Hempel, A.M. 
UJ8533 NA1000 3xFlag-tacA von Arx, C. 
UJ8961 NA1000 3xFlag-tacA r-cdG0 Hempel, A.M. 
UJ8888 NA1000 3xFlag-shkA DD (A513D, G514D) von Arx, C. 
UJ8926 NA1000 3xFlag-tacA DD (A491D, A492D) Hempel, A.M. 
UJ2827 NA1000 ΔpopA Duerig et al., 2009 
UJ3628 NA1000  ΔrcdA McGrath et al., 2006 
UJ3656 NA1000  ΔpopA ΔrcdA Duerig et al., 2009 
UJ4373 NA1000 ΔcpdR Skerker et al., 2005 
UJ4401 NA1000 ΔpopA  ΔcpdR Duerig et al., 2009 
UJ9455 NA1000 3xFlag-tacA ΔpopA von Arx, C. 
UJ9456 NA1000 3xFlag-tacA ΔrcdA von Arx, C. 
UJ9457 NA1000 3xFlag-tacA ΔrcdA ΔpopA von Arx, C. 
UJ9458 NA1000 3xFlag-tacA ΔcpdR von Arx, C. 
UJ9459 NA1000 3xFlag-tacA ΔcpdR ΔpopA von Arx, C. 
UJ9554 NA1000 3xFlag-shkA ΔpdeA von Arx, C. 
UJ9460 NA1000 3xFlag-shkA ΔpopA von Arx, C. 
UJ9555 NA1000 3xFlag-shkA ΔpopA ΔpdeA von Arx, C. 
UJ9461 NA1000 3xFlag-shkA ΔrcdA von Arx, C. 
UJ9556 NA1000 3xFlag-shkA ΔrcdA ΔpdeA von Arx, C. 
UJ9462 NA1000 3xFlag-shkA ΔrcdA ΔpopA von Arx, C. 
UJ9557 NA1000 3xFlag-shkA ΔrcdA ΔpopA ΔpdeA von Arx, C. 
UJ9463 NA1000 3xFlag-shkA ΔcpdR von Arx, C. 
UJ9558 NA1000 3xFlag-shkA ΔcpdR ΔpdeA von Arx, C. 
UJ9464 NA1000 3xFlag-shkA ΔcpdR ΔpopA von Arx, C. 
UJ9559 NA1000 3xFlag-shkA ΔcpdR ΔpopA ΔpdeA von Arx, C. 
SoA0764 NA1000 r-cdG0 Abel et al., 2013 
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SoA1587 NA1000 r-cdG0::dgcZ Abel et al., 2013 
UJ9619 NA1000 r-cdG0 shkA D369N Kaczmarczyk, A. 
UJ9170 NA1000 tacA DD (A491D, A492D) von Arx, C. 
UJ8987 NA1000 tacA D54E von Arx, C. 
UJ9621 NA1000 tacA DD (A491D, A492D) shkA D369N Kaczmarczyk, A. 
UJ9701 NA1000 shkA DD (A513D, G514D) von Arx, C. 
UJ9168 NA1000 shkA DD (A513D, G514D) TacA DD (A491D, A492D) von Arx, C. 
UJ9703 NA1000 shkA D369N DD (A513D, G514D) von Arx, C. 
UJ9620 NA1000 r-cdG0::dgcZ shkA D369N Kaczmarczyk, A. 
UJ5059 NA1000 cdG0::pleD Abel et al., 2013 
UJ4450 NA1000 ∆pleD Abel et al., 2013 
UJ4449 NA1000 ∆dgcB Abel et al., 2013 
UJ5790 NA1000 ∆pleD ∆dgcB Abel et al., 2013 
UJ4454 NA1000 ∆pdeA Abel et al., 2013 
UJ9412 NA1000 tacA D54E DD (A491D, A492D) von Arx, C. 
UJ9618 NA1000 shkA D369N Kaczmarczyk, A. 
UJ6712 NA1000 ∆spmY Nesper, J. 
UJ8568 NA1000 ∆tacA von Arx, C. 
UJ4687 NA1000 ∆spmX Radhakrishnan et al., 2008 
UJ998 NA1000 ∆divJ Aldridge et al., 2003 
UJ506 NA1000 ∆pleC Aldridge et al., 2003 
UJ508 NA1000 ∆pleC ∆pleD Aldridge et al., 2003 
UJ999 NA1000 ∆divJ ∆pleD Aldridge et al., 2003 
UJ1001 NA1000 ∆divJ ∆pleC ∆pleD Aldridge et al., 2003 
UJ1000 NA1000 ∆divJ ∆pleC Aldridge et al., 2003 
SoA1293 NA1000 cdG0::dgcZ Abel et al., 2013 
AKS217 
NA1000 shkA D369N DD (A513D, G514D) tacA DD (A491D, 
A492D) 
Kaczmarczyk, A. 
UJ9685 NA1000 3xFlag-tacA shkA D369N Kaczmarczyk, A. 
UJ9686 NA1000 cdG0 3xFlag-tacA shkA D369N Kaczmarczyk, A. 
UJ9687 NA1000 3xFlag-tacA DD (A491D, A492D) shkA D369N Kaczmarczyk, A. 
UJ9688 NA1000 cdG0 3xFlag-tacA DD (A491D, A492D) shkA D369N Kaczmarczyk, A. 
UJ8964 NA1000 ∆shkA tacA D54E Hempel, A.M. 
UJ8971 NA1000 r-cdG0 tacA D54E von Arx, C. 
UJ8976 NA1000 cdG0 tacA D54E 1 von Arx, C. 
UJ8977 NA1000 cdG0 tacA D54E 2 von Arx, C. 
7.2 PLASMIDS 
pAK502: Part of lacZ was PCR-amplified from pAK501 using primers 9060/9061, the product 
was digested with KpnI/DraIII and cloned into pAK501 digested with the same enzymes. 
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pAK503: nptII without RBS and start codon was PCR-amplified from pAK405 using primers 
8959/9495, the product was digested with BsrGI/XbaI and cloned into pAK501 cut with 
Acc65I/XbaI. 
pAK502-spmX: The spmX promoter and part of the codon sequence were PCR-amplified from 
C. crescentus gDNA using primers 8966/9064, the product was digested with XbaI/KpnI and 
cloned into pAK502 digested with the same enzymes. 
pAK503-spmX: The spmX promoter and part of the codon sequence were PCR-amplified from 
C. crescentus gDNA using primers 8966/9064, the product was digested with XbaI/KpnI and 
cloned into pAK503 digested with the same enzymes. 
pNPTStet: tetA and tetR were PCR-amplified from pQF using primers 9552/9553, the product 
was digested with SpeI/NdeI and cloned into pNPTS138 digested with AseI/XbaI. 
pNPTStet-ampG: Part of ampG located downstream of shkA was PCR-amplified from C. 
crescentus gDNA with primers 9554/9555, the product was digested with SpeI/KpnI and cloned 
into pNPTStet digested with the same enzymes. 
pET28a-shkA: shkA was PCR-amplified from C. crescentus gDNA with primers 9745/9746, the 
product was digested with NdeI/EcoRI and cloned into pET28a digested with the same 
enzymes. 
pET28a-shkA(D369N): shkA(D369N) was amplified from C. crescentus strain UJ9618 by colony-
PCR using primers 9745/9746, the product was digested with NdeI/EcoRI and cloned into 
pET28a digested with the same enzymes. 
pQF-shkA: shkA was PCR-amplified from C. crescentus gDNA with primers 9745/9746, the 
product was digested with NdeI/EcoRI and cloned into pQF digested with AseI/EcoRI. 
pQF-shkA(D369N): shkA(D369N) was amplified from C. crescentus strain UJ9618 by colony-
PCR using primers 9745/9746, the product was digested with NdeI/EcoRI and cloned into pQF 
digested with AseI/EcoRI. 
pQF-shkA(R26A): The mutant allele was generated by SOE-PCR using pET28a-shkA as template 
and flanking primers 669/670 and mutagenic primers 9904/9905. The product was digested 
with NdeI/EcoRI and cloned into pQF digested with AseI/EcoRI. 
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pQF-shkA(H61A): The mutant allele was generated by SOE-PCR using pET28a-shkA as template 
and flanking primers 669/670 and mutagenic primers 9968/9969. The product was digested 
with NdeI/EcoRI and cloned into pQF digested with AseI/EcoRI. 
pQF-shkA(R74A): The mutant allele was generated by SOE-PCR using pET28a-shkA as template 
and flanking primers 669/670 and mutagenic primers 9970/9971. The product was digested 
with NdeI/EcoRI and cloned into pQF digested with AseI/EcoRI. This shkA allele contains a 
second mutation, A451V. 
pQF-shkA(W113A): The mutant allele was generated by SOE-PCR using pET28a-shkA as 
template and flanking primers 669/670 and mutagenic primers 9906/9907. The product was 
digested with NdeI/EcoRI and cloned into pQF digested with AseI/EcoRI. This shkA allele 
contains a second mutation, A451V. 
pQF-shkA(D125N): The mutant allele was generated by SOE-PCR using pET28a-shkA as 
template and flanking primers 669/670 and mutagenic primers 10009/10010. The product was 
digested with NdeI/EcoRI and cloned into pQF digested with AseI/EcoRI. 
pQF-shkA(R128A): The mutant allele was generated by SOE-PCR using pET28a-shkA as 
template and flanking primers 669/670 and mutagenic primers 10005/10006. The product was 
digested with NdeI/EcoRI and cloned into pQF digested with AseI/EcoRI. 
pQF-shkA(R130A): The mutant allele was generated by SOE-PCR using pET28a-shkA as 
template and flanking primers 669/670 and mutagenic primers 10007/10008. The product was 
digested with NdeI/EcoRI and cloned into pQF digested with AseI/EcoRI. 
pQF-shkA(R128A,R130A): The mutant allele was generated by SOE-PCR using pET28a-shkA as 
template and flanking primers 669/670 and mutagenic primers 9908/9909. The product was 
digested with NdeI/EcoRI and cloned into pQF digested with AseI/EcoRI. 
pQF-shkA(R177A): The mutant allele was generated by SOE-PCR using pET28a-shkA as 
template and flanking primers 669/670 and mutagenic primers 9910/9911. The product was 
digested with NdeI/EcoRI and cloned into pQF digested with AseI/EcoRI. This shkA allele 
contains a second mutation, P233L. 
pQF-shkA(F230A,F234A): The mutant allele was generated by SOE-PCR using pET28a-shkA as 
template and flanking primers 669/670 and mutagenic primers 9972/9973. The product was 
digested with NdeI/EcoRI and cloned into pQF digested with AseI/EcoRI. 
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pQF-shkA(D297N): The mutant allele was generated by SOE-PCR using pET28a-shkA as 
template and flanking primers 669/670 and mutagenic primers 9974/9975. The product was 
digested with NdeI/EcoRI and cloned into pQF digested with AseI/EcoRI. 
pQF-shkA(P321A): The mutant allele was generated by SOE-PCR using pET28a-shkA as 
template and flanking primers 669/670 and mutagenic primers 10013/10014. The product was 
digested with NdeI/EcoRI and cloned into pQF digested with AseI/EcoRI. 
pQF-shkA(R324A): The mutant allele was generated by SOE-PCR using pET28a-shkA as 
template and flanking primers 669/670 and mutagenic primers 9912/9913. The product was 
digested with NdeI/EcoRI and cloned into pQF digested with AseI/EcoRI. 
pQF-shkA(D325N): The mutant allele was generated by SOE-PCR using pET28a-shkA as 
template and flanking primers 669/670 and mutagenic primers 10011/10012. The product was 
digested with NdeI/EcoRI and cloned into pQF digested with AseI/EcoRI. 
pQF-shkA(I327A): The mutant allele was generated by SOE-PCR using pET28a-shkA as template 
and flanking primers 669/670 and mutagenic primers 9976/9977. The product was digested 
with NdeI/EcoRI and cloned into pQF digested with AseI/EcoRI. This shkA allele contains a 
second mutation, A451V. 
pQF-shkA(Y338A): The mutant allele was generated by SOE-PCR using pET28a-shkA as 
template and flanking primers 669/670 and mutagenic primers 9978/9979. The product was 
digested with NdeI/EcoRI and cloned into pQF digested with AseI/EcoRI. 
pQF-shkA(R344A): The mutant allele was generated by SOE-PCR using pET28a-shkA as 
template and flanking primers 669/670 and mutagenic primers 9914/9915. The product was 
digested with NdeI/EcoRI and cloned into pQF digested with AseI/EcoRI. This shkA allele 
contains a second mutation, A451V. 
pQF-shkA(E402A,G403A): The mutant allele was generated by SOE-PCR using pET28a-shkA as 
template and flanking primers 669/670 and mutagenic primers 9980/9981. The product was 
digested with NdeI/EcoRI and cloned into pQF digested with AseI/EcoRI. 
pQF-shkA(C404A): The mutant allele was generated by SOE-PCR using pET28a-shkA as 
template and flanking primers 669/670 and mutagenic primers 9986/9987. The product was 
digested with NdeI/EcoRI and cloned into pQF digested with AseI/EcoRI. 
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pQF-shkA(D430N): The mutant allele was generated by SOE-PCR using pET28a-shkA as 
template and flanking primers 669/670 and mutagenic primers 10028/10029. The product was 
digested with NdeI/EcoRI and cloned into pQF digested with AseI/EcoRI. 
pQF-shkA(D465A): The mutant allele was generated by SOE-PCR using pET28a-shkA as 
template and flanking primers 669/670 and mutagenic primers 9982/9983. The product was 
digested with NdeI/EcoRI and cloned into pQF digested with AseI/EcoRI. This shkA allele 
contains a second mutation, A451V. 
pQF-shkA(C469A): The mutant allele was generated by SOE-PCR using pET28a-shkA as 
template and flanking primers 669/670 and mutagenic primers 9984/9985. The product was 
digested with NdeI/EcoRI and cloned into pQF digested with AseI/EcoRI. This shkA allele 
contains a second mutation, A451V. 
pQF-shkA(D369N,H61A): A fragment harboring part of shkA was released from pQF-
shkA(H61A) by digestion with SpeI/PstI and cloned into pQF-shkA(D369N) digested with the 
same enzymes. 
pQF-shkA(D369N,R128A): A fragment harboring part of shkA was released from pQF-
shkA(R128A) by digestion with SpeI/PstI and cloned into pQF-shkA(D369N) digested with the 
same enzymes. 
pQF-shkA(D369N,R130): A fragment harboring part of shkA was released from pQF-
shkA(R130A) by digestion with SpeI/PstI and cloned into pQF-shkA(D369N) digested with the 
same enzymes. 
pQF-shkA(D369N,R128A,R130A): A fragment harboring part of shkA was released from pQF-
shkA(R128A,R130A) by digestion with SpeI/PstI and cloned into pQF-shkA(D369N) digested 
with the same enzymes. 
pQF-shkA(D369N,F230A,F234A): A fragment harboring part of shkA was released from pQF-
shkA(F230A,F234A) by digestion with SpeI/PstI and cloned into pQF-shkA(D369N) digested 
with the same enzymes. 
pQF-shkA(D369N,R128A): A fragment harboring part of shkA was released from pQF-
shkA(R128A) by digestion with SpeI/PstI and cloned into pQF-shkA(D369N) digested with the 
same enzymes. 
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pQF-shkA(D369N,R324A): A fragment harboring part of shkA was released from pQF-
shkA(R324A) by digestion with SpeI/PstI and cloned into pQF-shkA(D369N) digested with the 
same enzymes. 
pQF-shkA(D369N,Y338A): A fragment harboring part of shkA was released from pQF-
shkA(Y338A) by digestion with SpeI/PstI and cloned into pQF-shkA(D369N) digested with the 
same enzymes. 
pET28a-shkA(D430N): The mutant allele was generated by SOE-PCR using pET28a-shkA as 
template and flanking primers 669/670 and mutagenic primers 10028/10029. The product was 
digested with NdeI/EcoRI and cloned into pET28a digested with NdeI/EcoRI. 
pET28a-shkA(E386Q,D387N): The mutant allele was generated by SOE-PCR using pET28a-shkA 
as template and flanking primers 669/670 and mutagenic primers 10026/10027. The product 
was digested with NdeI/EcoRI and cloned into pET28a digested with NdeI/EcoRI. 
pET28a-shkA(K480R): The mutant allele was generated by SOE-PCR using pET28a-shkA as 
template and flanking primers 669/670 and mutagenic primers 10024/10025. The product was 
digested with NdeI/EcoRI and cloned into pET28a digested with NdeI/EcoRI. 
pET28a-shkA(R324A): A fragment harboring part of shkA was released from pQF-shkA(R324A) 
by digestion with AscI/PstI and cloned into pET28a-shkA digested with the same enzymes. 
pET28a-shkA(D369N,R324A): A fragment harboring part of shkA was released from pQF-
shkA(R324A) by digestion with AscI/PstI and cloned into pET28a-shkA(D369N) digested with 
the same enzymes. 
pET28a-shkA(Y338A): A fragment harboring part of shkA was released from pQF-shkA(Y338A) 
by digestion with AscI/PstI and cloned into pET28a-shkA digested with the same enzymes. 
pET28a-shkA(D369N,Y338A): A fragment harboring part of shkA was released from pQF-
shkA(Y338A) by digestion with AscI/PstI and cloned into pET28a-shkA(D369N) digested with 
the same enzymes. 
pET28a-shkA(R128A,R130A): The mutant allele was generated by SOE-PCR using pET28a-shkA 
as template and flanking primers 669/670 and mutagenic primers 9908/9909. The product was 
digested with NdeI/EcoRI and cloned into pET28a digested with the same enzymes. 
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pDivJ-mCherry: The 3’ part of divJ was PCR-amplified from C. crescentus gDNA with primers 
10205/10206, the product was digested with KpnI/AgeI and cloned into pCHYC-4 digested with 
the same enzymes. 
pNPTS138-ΔtacA: Two DNA fragments flanking the tacA ORF were PCR-amplified from C. 
crescentus gDNA. Fragment 1 was amplified with primers 6535/6098, then digested with 
PstI/KpnI. Fragment 2 was amplified with primers 6098/6536, then digested with KpnI/EcoRI. 
The two fragments were ligated to pNPTS138 digested with PstI/EcoRI. 
pNPTS138-ΔshkA: Two DNA fragments flanking the shkA ORF were PCR-amplified from C. 
crescentus gDNA. Fragment 1 was amplified with primers 6085/6086, then digested with 
PstI/KpnI. Fragment 2 was amplified with primers 6087/6088, then digested with KpnI/EcoRI. 
The two fragments were ligated to pNPTS138 digested with PstI/EcoRI. 
pNPTS138-3xFlag-Tag-tacA: The upstream region of the tacA ORF was PCR-amplified from C. 
crescentus gDNA with primers 6438/6439 (fragment 1). A 3’ part of tacA was PCR-amplified 
from C. crescentus gDNA with primers 6440/7604 (fragment 2), and then used as a template 
with primers 6441/7604 to insert the coding sequence of the 3xFlag-Tag (fragment 3). SOE-PCR 
was performed with fragment 1 and 3 as template and primers 6438/7604. The resulting 
product was then digested with PstI/EcoRI and ligated into pNPTS138 digested with the same 
enzymes. 
pNPTS138-3xFlag-Tag-shkA: The upstream region of the shkA ORF was PCR-amplified from C. 
crescentus gDNA with primers 6442/6443 (fragment 1). A 3’ part of shkA was PCR-amplified 
from C. crescentus gDNA with primers 6444/7605 (fragment 2), and then used as a template 
with primers 6444/7605 to insert the coding sequence of the 3xFlag-Tag (fragment 3). SOE-PCR 
was performed with fragment 1 and 3 as template and primers 6442/7605. The resulting 
product was then digested with PstI/EcoRI and ligated into pNPTS138 digested with the same 
enzymes.  
pNPTS138-shkA-DD: The 5’ region of shkA was PCR-amplified from C. crescentus gDNA with 
primers 8169/8170 (fragment 1). The downstream region of the shkA ORF was PCR-amplified 
from C. crescentus gDNA with primers 8171/8172 (fragment 2). SOE-PCR was performed with 
the two fragments as template and primers 8169/8172. The resulting product was then 
digested with BamHI/EcoRI and ligated into pNPTS138 digested with the same enzymes. 
pNPTS138-tacA-DD: The 5’ region of tacA was PCR-amplified from C. crescentus gDNA with 
primers 7925/7716 (fragment 1). The downstream region of the tacA ORF was PCR-amplified 
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from C. crescentus gDNA with primers 7717/7718 (fragment 2). SOE-PCR was performed with 
the two fragments as template and primers 7925/7718. The resulting product was then 
digested with HindIII/EcoRI and ligated into pNPTS138 digested with the same enzymes. 
pNPTS138-tacA-D54E: The mutant allele was generated by SOE-PCR using C. crescentus gDNA 
as template and flanking primers 7958/7961 and mutagenic primers 7959/7960. The product 
was digested with PstI/EcoRI and cloned into pNPTS138 digested with the same enzymes. 
pNPTS138-3xFlag-tacA-D54E: The mutant allele was generated by SOE-PCR using C. crescentus 
gDNA of strain UJ8533 as template and flanking primers 7958/7961 and mutagenic primers 
7959/7960. The product was digested with PstI/EcoRI and cloned into pNPTS138 digested with 
the same enzymes. 
For in vitro experiments, proteins were expressed from pet28a and pet32b plasmids. 
pET28a-His-shkA: shkA was PCR-amplified from C. crescentus gDNA with primers 5988/5486, 
the product was digested with NdeI/HindIII and cloned into pET28a digested with the same 
enzymes. 
pET28a-His-shpA: shpA was PCR-amplified from C. crescentus gDNA with primers 6015/6016, 
the product was digested with HindIII/EcoRI and cloned into pET28a digested with the same 
enzymes. 
pET28a-His-tacA-RD: The sequence of tacA encoding the receiver domain was PCR-amplified 
from C. crescentus gDNA with primers 7925/6013, the product was digested with HindIII/EcoRI 
and cloned into pET28a digested with the same enzymes. 
pET32b-Trx-His-shkA-HK: The sequence of shkA encoding the kinase catalytic core including 
the REC1 domain was PCR-amplified from C. crescentus gDNA with primers 6110/6011, the 
product was digested with HindIII/EcoRI and cloned into pET32b digested with the same 
enzymes. 
pET32b-Trx-His-shkA-RD2: The sequence of shkA encoding the REC2 domain was PCR-
amplified from C. crescentus gDNA with primers 6109/6009, the product was digested with 
HindIII/EcoRI and cloned into pET32b digested with the same enzymes. 
pMT687-tacA: tacA was PCR-amplified from C. crescentus gDNA with primers 5487/5490, the 
product was digested with NdeI/KpnI and cloned into pMT687 digested with the same 
enzymes. 
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pMT687-tacA-DE: The mutant allele was generated by SOE-PCR using C. crescentus gDNA as 
template and flanking primers 5487/5490 and mutagenic primers 5488/5489. The product was 
digested with NdeI/KpnI and cloned into pNPTS138 digested with the same enzymes. 
pQF-PA5295: PA5295 was PCR-amplified from pRV-PA5295 with primers 8974/8975, the 
product was digested with HindIII/KpnI and cloned into pMT687 digested with the same 
enzymes. 
pQF-PA5295-AAL: PA5295AAL was PCR-amplified from pRV-PA5295AAL with primers 8974/8975, 
the product was digested with HindIII/KpnI and cloned into pMT687 digested with the same 
enzymes. 
pRKlac290-spmX: The promoter region of spmX was PCR-amplified from C. crescentus gDNA 
with primers 6864/6865. The resulting product was digested with EcoRI/PstI and ligated into 
pRKlac290 digested with the same enzymes. 
pRKlac290-staR: The promoter region of staR was PCR-amplified from C. crescentus gDNA with 
primers 6621/6622. The resulting product was digested with EcoRI/PstI and ligated into 
pRKlac290 digested with the same enzymes. 
pAH10 is a pUC19-derivative containing a NsiI-PacI-flanked cassette consisting of the rrnBT1 
terminators and a multiple cloning site. 
pAH87 is a low-copy replicative plasmid derivative of pMT375, in which the XbaI insert was 
replaced with the NsiI-PacI cassette of pAH10. 
pAH99 is a derivative of pAH87. The dendra2 gene was PCR-amplified from pDHL851 using 
primers 7503 and 7507, which also introduced a stop codon and the RBS of pQE70 upstream of 
dendra2. The product was digested with HindIII and PacI and ligated into pAH87 digested with 
the same restriction enzymes. 
pAH111: The promoter region and parts of the gene of spmX was PCR-amplified from C. 
crescentus genomic DNA with primers 6864 and 7512. The resulting product was digested with 
EcoRI and HindIII and ligated into pAH99 digested with the same enzymes to generate a 
transcriptional fusion of dendra2 to the spmX promoter. 
7.3 GROWTH CONDITIONS 
Either Peptone Yeast extract medium (PYE) or minimal medium supplemented with glucose 
(M2G)207,208 was used to grow C. crescentus at 30°C. The appropriate antibiotics 
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(Chloramphenicol in PYE 1µg/ml, Kanamycin in PYE 5µg/ml, Oxytetracycline in PYE 2.5 µg/ml)  
were added under growth conditions with plasmids. Plasmids were induced with either 
Cumate or IPTG as indicated in the figures. Synchronization assays193 were performed with 
LUDOX 209 or Percoll™ (GE Healtcare) density gradients210 in M2G medium.  
7.4 PHOS-TAG IMMUNOBLOTTING 
C. crescentus overnight cultures were diluted 1:20 in PYE medium (containing 100µM cumate 
and 2.5µg/ml Oxytetracycline for strains harboring pQF plasmids). The bacteria were grown to 
an OD660 of 0.4 to 0.5 at 30°C. An equivalent of 0.5mL OD660 0.5 was spun down and lysed in 
100µL Lysis Buffer (10mM Tris-HCL pH7.5, 4% SDS, 1 PhosSTOP™ tablet (Roche) in 5mL volume, 
DNAse I (NEB)) for 5min at RT. After spinning down the samples for 5min at max speed and RT, 
80µL of full-cell lysate was taken up in 120µL 1.6X SDS sample buffer (0.1M Tris pH 6.8, 5% 
Glycerol, 0.2% SDS, 1% β-Mercaptoethanol, 0.025% Bromophenol blue) and kept on ice. 20µL 
was loaded on a gel and separated by 12% SDS-PAGE gels containing 100µM MnCl2 and 50µM 
Phos-tag™ compound (Wako)211 and run for 4 to 5 hours at 100V at 4°C. Transfer was 
performed for 2h at 80V using a BioRad® wet blot system at 4°C. The protein was transferred 
to PVDF-membranes (Immobilon-P, Millipore). 
An α-Flag antibody (F1804 Sigma, 1:10 000) was used as primary antibody, detected by HPR-
conjugated rabbit anti-mouse (DakoCytomation, DK) secondary antibody. ECL detection 
reagent (Perkin Elmer Life Sciences) was used for development on a photo film (Fuji). 
7.5 IMMUNOBLOTTING 
Cells were harvested and the OD660 normalized in 1x SDS sample buffer. All samples were 
boiled for 5min at 95°C and separated on 12% SDS-PAGE gels. Protein was transferred to PVDF-
membranes (Immobilon-P, Millipore 0.45µm). α-MreB (1:20 000), α-SpmX (1:10 000), or α-Flag 
(F1804 Sigma, 1:10 000) antibodies were used as primary antibodies. HPR-conjugated rabbit 
anti-mouse or swine anti-rabbit secondary antibodies (Dako) were used for detection. ECL 
detection reagent (Perkin Elmer Life Sciences) was used for development on a photo film (Fuji). 
7.6 CAPTURE COMPOUND MASS SPECTROMETRY (CCMS) 
Capture Compound Mass Spectrometry (CCMS) was performed for the discovery of new c-di-
GMP targets. Thereby an engineered trivalent chemical compound was used to isolate and 
analyze c-di-GMP binders. This compound consists of a c-di-GMP residue to specifically bind c-
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di-GMP-binders, an UV-photoactivatable reactive group, allowing crosslinking of captured 
proteins, and a biotin to purify the captured protein. The isolated proteins then were digested 
and analyzed by mass spectrometry203,212.  
7.7 PROTEIN EXPRESSION AND PURIFICATION 
E. coli BL21 Rosetta cells were used to express proteins from the pET28a and pET32b 
expression plasmids. The cells were grown to an OD600 of 0.4 to 0.6 and then induced with 
0.5mM IPTG for 4 hours at 30°C. Cells were harvested and frozen as pellets at -20°C. 
Purification was performed using an ÄKTApurifier 10 system (GE Healthcare) with 1ml HisTrap 
HP columns (GE Healthcare). To increase protein purity, the samples were run on a size 
exclusion column (HiLoad 16/60 Superdex 200). Buffers used for purification: Lysis buffer 
(Wash Buffer supplemented with protease inhibitor, DNase I (NEB)), Wash buffer (20mM 
HEPES-KOH pH 8.0, 0.5M NaCl, 10 % glycerol, 20mM imidazole, 1mM DTT), Elution buffer 
(20mM HEPES-KOH pH 8.0, 0.5M NaCl, 10% glycerol, 500mM imidazole, 1mM DTT), Storage 
buffer (10mM HEPES-KOH pH 8.0, 50mM KCl (or 100mM KCl), 10% glycerol, 0.1mM EDTA, 
1mM DTT). 
7.8 KINASE IN VITRO ASSAYS  
Kinase assays were adapted from10,213,214. Reactions were performed in Storage buffer 
supplemented with 500μM ATP and 5μCi [γ32P]-ATP (3000Ci/mmol, Hartmann Analytic) at RT. 
Additional nucleotides were added as indicated in figures. Kinase reactions were stopped with 
SDS sample buffer and stored on ice, then run on 12.5% SDS PAGE gels. Gels were exposed to 
phosphor screen for 0.5h to 3h and then scanned by a Typhoon FLA 7000 imaging system (GE 
Healthcare). 
7.9 ISOTHERMAL TITRATION CALORIMETRY (ITC) MEASUREMENTS  
ITC binding assays were performed with a VP-ITC isothermal titration calorimeter (MicroCal). 
Concentrations were 12μM ShkA in the cell and 130μM c-di-GMP in the syringe. ITC Buffer: 
10mM HEPES-KOH pH 8.0, 100mM NaCl, 10% glycerol, 1mM DTT. After a first injection of 3μl, 
10μl was injected at 29 time points. Data analysis was performed with MicroCal (ORIGIN) and 
fitted with the One binding site model of ORIGIN. 
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7.10 Β-GALACTOSIDASE MEASUREMENTS 
C. crescentus overnight cultures grown in PYE supplemented with 2.5µg/ml Oxytetracycline 
were resuspended in the same, fresh medium. The bacteria were grown to an OD660 of 0.3 to 
0.5 and 1ml was pelleted and resuspended with 1ml Z-buffer (75mM Na2HPO4, 40mM 
NaH2PO4, 1mM KCl, 1mM MgSO4; pH 7.0), supplemented with 50mM β-mercaptoethanol. 
Then 100µL 0.1% SDS and 20µL chloroform was added. Samples were vortexed for 10sec and 
lysed at RT for 0.5h to 1h. For every sample, 200µl was transferred to a 96-well plate with 
three biological replicates. 25μL of a 4mg/ml σ-nitrophenyl-β-D-galactopyranoside (σNPG) 
solution, dissolved in Z-buffer, was added as a substrate. Activity of the β-galactosidase was 
measured with a BioTek Instruments EL800 plate reader at 405nm (20 reads at the fastest 
interval). Activity was calculated as the initial slope at linear range.  
7.11 MICROSCOPY 
Phase-contrast and fluorescent microscopy analyses were performed using a DeltaVision 
system, Olympus IX71 microscope, and Photometrix CoolSnap HQ2 camera. Cells were 
mounted on 1% PYE medium agar pads containing appropriate supplements sealed with a 
double layer of gene frames (ABgene; 1.7 x 2.8 cm). For time-lapse, imaging pictures were 
taken every 15 minutes. Appropriate cells expressing dendra2 were subjected to UV light for 2 
seconds to switch dendra2 from the green to the red-emitting state. For statistical analysis, 
fluorescent intensities, cell and stalk length were analyzed using the Fiji software package215 
and Oufti216. 
7.12 SELECTION/SCREEN FOR C-DI-GMP INDEPENDENT MUTATIONS IN SHKA 
Six independent colonies of strain AKS1 (CB15 rcdG0 lacA:: ampG::pNPTStet-ampG) 
harboring in addition plasmid pAK503-spmX were inoculated into 5ml PYE containing 
Chloramphenicol (Cm) (1mg/l) and Tetracycline (Tc) (10mg/l) and grown overnight. For UV 
mutagenesis, 2ml of each culture was distributed in 6-well plates and irradiated with 10’000mJ 
UV light using a Stratalinker, after which 5ml PYE containing Cm (1mg/l) and Tc (10mg/l) were 
added and cultures grown for 7h at 30°C with shaking. 500µl of each culture were plated on 
PYE plates containing Cm (1mg/l), Tc (10mg/l) and Kanamycin (Km) (6.25mg/l) and plates 
incubated at 30°C for 4 days. All colonies from one plate were pooled, diluted to an OD660 of 
0.1 and grown for 7h at 30°C, and phage lysates were prepared for each independent pool. 
Following transduction of strain AKS17 (CB15 rcdG0 lacA::/pAK502-spmX) with individual 
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pool lysates, cells were plated on PYE containing Cm (1mg/l), Tc (10mg/l) and X-Gal (40mg/l) 
and incubated at 30°C for 3 days. Blue colonies were once re-streaked to confirm their blue 
colony phenotype, followed by colony PCR using primers 9765 and 9766 and sequencing 
(Microsynth, Balgach, Switzerland) of the PCR product using primers 9765, 9766, 6011 and 
6498. 
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